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This thesis summarizes the results of two major projects that have been completed enough              
to be published ​(Lounková et al. 2017; Přikryl et al. 2019) and one ongoing project. All deal                 
with variants of envelope glycoprotein, a protein vital for virus entry into the cell. As               
philosophers and biologists (one type of philosopher) agree, viruses are alive only inside             
living cells, and interactions of envelope glycoproteins with cell surface molecules, receptors,            
are a kind of kiss of the Prince to the Sleeping Beauty, as viruses attain “life” upon entering                  
the cell. In contrast to the breaking of sleeping spell bestowed upon Sleeping Beauty by               
being kissed by the Prince (classified as a 410 tale type by the Aarne-Thompson-Uther              
classification system for folktales), some viruses may (or have to) be kissed by multiple              
Princes and some can even awake themselves, unkissed (which is usually coupled with rage              
in the form of pathology to the host). 
All projects, as well as my entire work, strive to understand retroviral envelope glycoprotein              
interactions with respective receptors and non-receptor molecules and mechanisms of their           
function with a special interest in those exhibiting an extended host range. The work also               
includes unpublished results regarding the pathology of analyzed viruses. We believe that            
pathologies observed in our in vivo experiments highlight the importance of our work despite              
the fact that the symptoms and their underlying mechanisms remain mostly unexplained. 
The Introduction to this thesis presents a brief review of the envelope glycoproteins of avian               
leukosis viruses and their receptors, mechanism of fusion, viral entry, and pathology.            
Materials and Methods are a mixture of methodology and solutions used in all experiments.              
In Results, the results of the two published papers and one unfinished project are              
supplemented with pathological analyses. In Discussion, our data are discussed with           
prospects for future work on our own or by others who found our papers interesting. Taken                
together, although our work is not about a new breakthrough methodology such as CRISPR,              
or paradigm-changing hypotheses such as the provirus hypothesis, I believe it presents new             
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In my doctoral thesis, I focused on studying the envelope glycoprotein of ALV (Avian              
Leukosis Viruses), a group of retroviruses infecting Galliformes and inducing a variety of             
diseases. Eradication of these viruses in the farming industry is in progress and information              
about the virus spread, namely corresponding receptors, is needed to successfully           
accomplish this feat. Furthermore, many variants of retroviruses infect cells regardless of the             
absence of the corresponding receptor, and understanding of this phenomenon is also            
crucial. 
We analyzed a newly emerged subgroup of ALV, termed K for its sequence divergence from               
other subgroups, and determined its host range, interference, and receptor usage, to confirm             
whether this group deserves a new letter for its designation. We identified a receptor of               
ALV-K that proved to be Tva, the receptor also used by ALV-A. However, since the               
K subgroup differs from the A subgroup by its host range and inhibition by the soluble form                
of Tva, we expect the two subgroups use different epitopes of the Tva receptor. 
We also analyzed a variant of ALV-C exhibiting an extended host range as it successfully               
infected hamster cells. We found that the extended host range correlates with the ability of               
the envelope glycoprotein to acquire activated prefusion state prematurely, without          
interaction with the receptor, which was demonstrated by the same sensitivity to            
temperature, pH, and selective inhibitors of fusion as other cases of envelope glycoproteins             
with a propensity for premature activation. 
Finally, we tried to understand the cause and mechanism of virus-induced osteopetrosis, a             
disease characterized by bone enlargement caused by osteoblasts hyperproliferation. We          
compared the genome of a highly osteopetrotic strain, MAV-2.O, with non-osteopetrotic           
strains and verified the importance of the envelope glycoprotein gene in osteopetrosis            
induction. Furthermore, we analyzed its stability and ability to enter the cells lacking its              
receptor, Tvb. 
 





Ve své doktorské práci jsem se zaměřil na studium obalových glykoproteinů ALV (ptačích             
leukósových virů), skupiny retrovirů infikující hrabavé ptáky a vyvolávající řadu onemocnění.           
Informace o způsobech šíření viru, především o jejich receptorech, jsou nezbytné vzhledem            
k probíhající snaze o eradikaci těchto virů. Navíc, mnoho variant retrovirů infikuje buňky             
nezávisle na přítomnosti receptoru; pochopení tohoto jevu je rovněž nanejvýš důležité. 
Analyzovali jsme nově objevenou podskupinu ALV, označenou K pro její sekvenční odlišnost            
od ostatních podskupin a určili její hostitelský rozsah a interferenci, abychom potvrdili, že si              
tato skupina zaslouží nové písmeno. Identifikovali jsme receptor pro ALV-K, kterým se            
ukázal být Tva, receptor využívaný také ALV-A. Vzhledem k rozdílům v hostitelském            
rozsahu a rozdílné inhibici rozpustnou formou Tva ovšem předpokládáme, že tyto dvě            
podskupiny využívají rozdílné epitopy Tva receptoru. 
Také jsme analyzovali variantu ALV-C, vykazující rozšířený hostitelský rozsah, který se           
projevil její schopnosti infikovat křeččí buňky. Zjistili jsme, že rozšířený hostitelský rozsah            
koreluje se schopností obalového glykoproteinu přejít do aktivovaného předfúzního stavu          
předčasně, bez interakce s receptorem, což bylo demonstrováno stejnou citlivostí na teplotu,           
pH a selektivní inhibitory fúze jako v jiných případech obalových glykoproteinů s náchylností           
k předčasné aktivaci. 
Nakonec jsme se pokusili porozumět příčině a mechanismu virové osteopetrózy,          
onemocnění charakterizovaného zvětšením kostí způsobeným hyperproliferací osteoblastů.       
Porovnali jsme genom vysoce osteopetrotického kmenu, MAV-2.O, s neosteopetrotickými         
kmeny a ověřili důležitost genu obalového glykoproteinu v indukci osteopetrózy. Dále jsme            
analyzovali jeho stabilitu a schopnost vstoupit do buněk postrádající jeho receptor, Tvb. 
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ALV Avian leukosis viruses 
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APOBEC Apolipoprotein B mRNA 
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CEF Chicken embryo fibroblasts 
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CPSF6 Cleavage and 
polyadenylation specificity 
factor subunit 6 
CRD Cysteine-rich domains 
CRISPR Clustered regularly 
interspaced short 
palindromic repeats 
CV Northern bobwhite 
CXCR4 C-X-C chemokine receptor 
type 4 
DNA Deoxyribonucleic acid 
EAV Endogenous retrovirus 
ECL Extracellular loop 
EDTA Ethylenediaminetetraacetic  
acid 
ENA Enzootic nasal 
adenocarcinoma 
ENTV Enzootic nasal tumor virus 
ENV Envelope glycoprotein 
EpoR Erythropoietin receptor 




ERV Endogenous retrovirus 
EtOH Ethyl alcohol 
F-MuLV Friend murine leukemia 
virus 
FACS Fluorescent Activated Cell 
Sorting 
FACT facilitates chromatin 
transcription 
FCS Fetal chicken serum 
FFU Focus forming units 
FGV Fowl glioma virus 
FP Fusion peptide 




GFP Green fluorescent protein 




GPV Golden pheasant virus 
GQV Gambel's quail virus 
gRNA Genome RNA 
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virus 
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JSRV Jaagsiekte sheep retrovirus 
L Leucine 
LDL Low-density lipoprotein 
LDLR Low-density lipoprotein 
receptor 
LL White-crested kalij 
pheasant 
LMP Low melting point 
LPS Lipopolysaccharides 
LN Silver pheasant 
LTR Long terminal repeat 
M Turkey 
MA Matrix protein 
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MEK Mitogen-activated protein 
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MMTV Mouse mammary tumor 
virus 
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domain-containing protein 1 
SD Splicing donor 
SDS Sodium Dodecyl Sulfate 
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focus-forming virus 
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Retroviruses are infectious agents that can be found in most vertebrates and cause a variety               
of diseases. They have been known for more than a century and also became recognized by                
the general public because of the HIV (Human Immunodeficiency virus) outbreak in the             
1980s resulting in AIDS (Acquired Immune Deficiency Syndrome) worldwide pandemic. In           
addition to immunodeficiency, retrovirus-related pathologies include tumorigenesis, wasting        
syndrome, anemia, and several others. Some are causing huge health problems in humans             
(AIDS and leukemia) or economical losses in farming (leukosis of hens). 
Retroviruses piqued the interest of researchers on two major occasions. First, after their             
discovery at the beginning of the 20th century when their ability to induce tumors was               
observed ​(Rous 1910; Ellermann and Bang 1909; Rous 1911)​. Second, after the discovery             
of their replication protein, reverse transcriptase, an enzyme converting RNA to DNA,            
challenged the central dogma of molecular biology in the 1970s ​(Baltimore 1970; Temin and              
Mizutani 1970)​.  
The Retrovirus family comprises viruses sharing the following essential features: they are            
enveloped viruses (i.e. wrapped into a membrane of cellular origin) that carry a             
pseudodiploid genome with two single-stranded RNAs of (+) polarity encoding three major            
polyproteins: gag, pol, and env. During the retrovirus life cycle, the RNA undergoes             
transcription into DNA which then integrates into the host genome and forms a provirus              
flanked by two identical LTRs (long terminal repeats). Retroviruses are further divided into             
several genera. Alpharetroviruses and gammaretroviruses are called simple retroviruses         
since they do not code for any accessory protein, while betaretroviruses deltaretroviruses,            
epsilonretroviruses, and lentiviruses are known as complex retroviruses for encoding many           
accessory proteins regulating their life cycle. 
The Retrovirus family also contains a subfamily of spumaviruses with no disease            
association, thus being out of the mainstream of interest. 
ALVs studied in this thesis constitute the major group of Alpharetroviruses and bear only              
basic genetic equipment. 
Alpharetrovirus life cycle 
The interaction of env (envelope glycoprotein) spikes on the virion surface with receptors on              
the surface of the target cell starts a series of events ending by the release of the viral core                   
into the cytoplasm (for more details see next chapter). This is followed by uncoating (viral               
core disassembly), reverse transcription of the single-stranded RNA genome into the           
double-stranded DNA form and its integration into the host genome thereby becoming a             
provirus. As ALVs encode no accessory proteins and their proteins harbor no nuclear import              
signals, there is no way for them to enter the nucleus via an active process thus, they have                  
to wait for the disintegration of the nuclear envelope during mitosis to reach the host               
genome. Integration of viral DNA is promoted by association of the integrasome with the              
FACT (facilitates chromatin transcription) complex ​(Winans et al. 2017)​. The selection of            
integration sites is close to random. 
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ALV transcription driven by the promoter and enhancer contained within LTR leads to the              
production of unspliced RNA and a single form of spliced mRNA. Unspliced mRNA codes for               
both gag (group-specific antigen) and pol (polymerase) proteins, initially in the form of a              
polyprotein which, inside the virion and simultaneously with the process of virus budding, is              
cleaved by viral protease into a series of subunits. Gag-derived subunits are MA (matrix), CA               
(capsid), and NC (nucleocapsid) proteins that together form the virion core, pol-derived are             
replicative proteins PR (protease), RT (reverse transcriptase), and IN (integrase). Spliced           
mRNA is translated into the env precursor protein, cleaved, and subsequently glycosylated            
in the Golgi apparatus into the SU (surface) subunit responsible for receptor recognition and              
the TM (transmembrane) subunit responsible for virion anchoring and fusion of membranes;            
the subunits remain linked together via disulfide bonds.  
Unspliced mRNA also serves as gRNA (genome RNA), which after dimerization is            
encapsulated by assembling gag-pol polyproteins beneath the surface of the host membrane            
enriched by env spikes, followed by virus budding and so-called maturation - cleavage of              
proteins by PR inside the virion. 
Permissive cells and restriction factors 
Retroviruses penetrated nearly all branches of life. This wide distribution of retroviruses is             
accompanied by diversification as retroviruses have to adapt to the specific environment in             
certain hosts. Retroviruses strongly depend on cellular factors (virus dependence factors) at            
all steps of their replication cycle and many of these factors are species-specific. Thus,              
retroviruses can enter only susceptible cells and replicate only in permissive cells. Any             
change in the host range of a given retrovirus must be accompanied by the evolution of the                 
viral proteins, particularly the envelope glycoproteins. Co-evolution of retroviruses and hosts           
is continual and host cells cope with selection pressure imposed by retroviruses by changes              
or loss of virus dependence factors (e.g. receptors for retroviruses).  
Another anti-retroviral strategy of the hosts is the expression of restriction factors, which             
interfere with the virus life cycle. Restriction factors typically obstruct virus entry (SERINC             
family - ​Rosa et al. 2015​, IFITM family - ​Bailey et al. 2014​) reverse transcription and                
replication (APOBEC family - ​Mangeat et al. 2003​, Samhd1 - ​Laguette et al. 2011​, CEM15 -                
Sheehy et al. 2002​), uncoating (TRIM5α - ​Gao, Guo, and Goff 2002)​, nuclear entry (CPSF6 -                
Lee et al. 2010​) viral mRNA production (ZAP - ​Gao, Guo, and Goff 2002​), and virus release                 
(tetherin - ​Neil, Zang, and Bieniasz 2008​, also called BST-2 - ​Van Damme et al. 2008​). Most                 
restriction factors have been identified in HIV-1- and MLV-resistant cells whereas restriction            
factors blocking the replication cycle of e.g. avian leukosis virus remain to be systematically              
explored ​(Krchlíková et al. 2020)​. 
An excellent example of cell non-permissiveness is the mammalian cell lines transformed            
with avian Rous sarcoma virus (RSV), which do not express viral mRNAs and produced no               
viral progeny ​(Svoboda et al. 1963) until cell fusion with permissive chicken fibroblasts             
complements the lacking virus dependence factors ​(Svoboda and Dourmashkin 1969;          
Machala, Donner, and Svoboda 1970)​. A similar phenomenon was observed in rodent cells             
non productively infected by HIV. Virus replication was forced upon cell fusion with             
permissive human cells ​(Bieniasz and Cullen 2000; Mariani et al. 2000)​. The nature of              
permissiveness-inducing factors remains to be solved, while the first evidence of mRNA            
17 
 
aberrant splicing and impaired nuclear export in RSV-infected mammal cells is being            
collected ​(Lounková et al. 2014)​. 
 
 
Figure 1.: Scheme of retrovirus life cycle 
The first step of the retrovirus life cycle consists of interaction with specific receptors (and in                
some cases co-receptors) and fusion of viral and host membranes (1.). The fusion may              
occur immediately, on the plasma membrane (HIV) or later, in an acidified endosome (ALV).              
Virus entry is followed by the import of capsid core into the cell nucleus, reverse transcription                
(2.), uncoating, and integration of proviral DNA into the host genome occurs (3.). LTR-driven              
transcription generates spliced and unspliced RNAs (4.), which are exported from the            
nucleus (5.) to serve as a template for translation (6.) or to associate with Gag (7.,8.). As the                  
immature virus particles are assembling beneath the surface of cells (9.), they interact with              
newly synthesized envelope glycoproteins and leave the cells through budding of the host             






Cell entry mediated by envelope glycoprotein 
The first step in the retrovirus life cycle, attachment of the virion to the cell membrane                
followed by virus entry, is mediated by the interaction between virus env (ligand) and              
corresponding cell surface protein (receptor). 
Although env sequences and properties differ among retroviral genera, they share basic            
hallmarks. Env is translated as a polyprotein consisting of a signal peptide, SU, and TM               
subunits. As the nascent env is being translated, the signal peptide binds to the signal               
recognition particle and becomes associated with the membrane of the ER (endoplasmic            
reticulum). Restored translation extrudes most of the polyprotein into the lumen of the ER              
and becomes anchored via a hydrophobic sequence (called transmembrane or          
membrane-spanning domain) near the C-terminus. As soon as the translation is finished, the             
polyprotein forms trimers via a homo-binding domain localized at the TM subunit. After             
cleavage of the signal peptide, the polyprotein is transported to the Golgi apparatus where              
N-glycosylation and proteolytic cleavage by furin or furin-like proprotein convertase takes           
place, producing SU and TM subunits linked through disulfide bonds at the C-terminus and              
N-terminus, respectively ​(Wills, Srinivas, and Hunter 1984; Perez and Hunter 1987)​. 
The signal peptide was shown to play an important role in the life cycle of some retroviruses                 
upon entering the nucleus; however, this was not proved in the case of ALVs ​(Yolitz et al.                 
2018; Hofacre, Nitta, and Fan 2009)​. 
The SU subunit is responsible for receptor recognition. Five regions of ALVs SU were              
suggested to be the most important for this feat and designated vr1-3 (variable regions 1-3)               
for shorter regions and hr1-2 (host range regions 1-2) for longer regions. This hypothesis              
was formulated based on the fact that a large proportion (20-40 %) of sequence differences               
between envs of different subgroups are concentrated in these relatively short regions.            
Analysis of chimeras between selected envs identified hr1, hr2, and v3 as the major players               
since their switching shifted receptor usage and host range towards receptor usage and host              
range of the donor molecule while switching vr1 and vr2 had no effect ​(Bova, Olsen, and                
Swanstrom 1988; Bova, Manfredi, and Swanstrom 1986)​.  
While the SU subunit is highly variable, the TM subunit is the most conserved part of the                 
envelope glycoprotein. This is not surprising since the TM subunit is not involved in receptor               
recognition and thus is not subject to selective pressure during the evolutionary arms race              
between the virus and its host where receptor usage changes are typical events. On the               
contrary, the TM subunit represents a device for the fusion of viral and cellular membranes,               
a crucial and highly orchestrated event, and most changes in TM might interfere with it. 
The TM subunit contains five regions worth mentioning. The fusion peptide at the N-terminus              
is a hydrophobic sequence that is hidden within the env trimeric structure until the              
virus-receptor interaction occurs. This interaction induces conformational changes of SU          
evoking the whole env trimer rearrangement leading to exposure of fusion peptides before             
they get inserted into the cell membrane so-called priming ​(Walther Mothes et al. 2000)​. The               
virion is thus anchored to the cell via TM subunit already hooked up in the virion by its                  
transmembrane domain (another hydrophobic sequence near the C-terminus). While         
anchored, the virion is transferred inside the cell by endocytosis. As the endosome matures,              
its inner environment is acidified. Protonation of two TM regions, HR1 and HR2 (heptad              
repeats 1 and 2), increases their affinity to each other and promotes the formation of               
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six-helix bundles concurrently aligning viral and endosomal membranes along with each           
other. This is followed by spontaneous lipid bilayer fusion and pore formation for releasing              
the virion core into the cell cytoplasm. The last TM region worth mentioning is its intracellular                
C-terminus. A role in virion assembly, fusion, immunosuppression, and pathogenicity was           




Figure 2.: Steps of env-driven membrane fusion 
(A) The envelope glycoprotein anchored in the membrane of the virion in close proximity to               
the host cell membrane (i) undergoes structural changes upon interaction with the receptor,             
leading to exposure of the fusion peptides that insert into the host cell membrane (ii). A                
number of activated glycoproteins is necessary to cooperate (iii) in bending the membranes             
(iv), bringing them to close proximity until lipid monolayer mixing occurs (v) and a fusion pore                
is formed (vi). 
(B) The TM subunit consists of four regions involved in membrane fusion, fusion peptide              
(FP) responsible for attaching to the host membrane, two heptad repeats (N-HR and C-HR)              
which are attracted to each other upon protonation, bringing both membranes to close             
proximity and the transmembrane domain (TMD) anchoring the protein into the viral            





Classification and pathogenicity of Avian leukosis viruses 
ALV subgroups 
With the introduction of new techniques, such as agar overlay of cultures of chicken embryo               
cells at the end of the 1950s, a new era of retrovirology began. In the following years, in vitro                   
experiments with RSV (the first member of alpharetrovirus family identified) revealed that            
some embryo-derived cell cultures contain transmissible resistance factors blocking RSV          
foci induction. Analysis of these factors leads to the discovery of a set of avian retroviruses                
persisting in chicken flocks due to vertical transmission from hens to the offspring. These              
retroviruses were similar to RSV in basic features except the ability to induce foci in cultures                
and sarcomas in chicken. They were termed ALV for their connection with avian leukosis. 
The above phenomenon, later named receptor interference (or superinfection interference),          
proved common across different viral genera, starting from bacteriophages and ending with            
retroviruses. Upon virus entry and envelope glycoprotein expression further entry of virions            
using the same receptor is blocked via either receptor downregulation caused by env binding              
or via receptor occupancy. Receptor downregulation was demonstrated in beta-, gamma-           
and delta- retroviruses. In the case of alpharetroviruses, however, some subgroups use the             
same receptor yet they poorly interfere with each other which implies two conclusions: first,              
these subgroups contact different epitopes on the same receptor, and second, the receptor             
downregulation by these subgroups, if any, is far from complete.  
Based on the interference of individual ALV strains with individual RSV strains, the first five               
subgroups were defined, termed A to E ​(Vogt and Ishizaki 1965)​. Later, F to I subgroups                
were established based on interference patterns of viruses released from non-gallus           
embryonic cells ​(Hanafusa et al. 1976)​. In 1987, a worldwide outbreak of myelocytomatosis             
in meat-type broilers was observed and linked to the spread of ALV of a novel subgroup,                
termed J ​(Payne, Gillespie, and Howes 1992)​. Lastly, in 2012, in an attempt to test a                
population of Luhua chickens for the presence of either J or A subgroup, viruses with env                
sequences distant from any other previously reported were found, possibly forming a new             
subgroup, termed K ​(Wang X., Zhao, and Cui 2012)​. 
Thus, 11 ALV subgroups have been identified so far, distinction and nomenclature of which              
is based on the host range and interference pattern which is in turn determined by the                
receptor they use and is reflected in the sequences of env. 
Subgroups of high risk to poultry: A, B, J, and K 
Subgroups A, B, J, and possibly K comprise naturally occurring exogenous viruses causing             
economic losses in poultry farming worldwide. In the past, the prevalence of ALV in              
commercial flocks was very high and the associated mortality rate was about 2 %. With               
improved hygienic standards and the selection of more viable lines, the mortality rate and              
virus prevalence dropped significantly. However, ALV-incurred depression of production         
(egg numbers, fertility, hatchability) is still significant and remains to be solved ​(Stedman and              
Brown 1999)​; ​(Lin et al. 2016)​.  
Different strains of ALV have a tendency to induce different diseases. The disease specificity              
generally reflects the virus tropism - the tissue in which the virus preferentially replicates.              
Tropism is primarily determined both by tissue specificity of expression of the receptor used              
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to enter the cell (i.e. by a subgroup) and by tissue specificity of the viral promoter and                 
enhancer contained within LTR. Other parts of the retroviral genome, however, may            
influence disease specificity as well. 
Subgroup A viruses have occurred frequently and still remain one of the most frequent types               
of avian retroviral infection ​(Fenton, Reddy, and Bagust 2005; Burstein et al. 1984; Zhang et               
al. 2010)​. Together with subgroup B viruses, which are rarer ​(D. Li et al. 2013)​, they induce a                  
variety of diseases, including a range of neoplasias (leukosis, erythroblastosis,          
myelocytomatosis, hemangiomas, gliomas, nephroblastomas, osteopetrosis, etc. ​(Hatai et        
al. 2008; Nakamura et al. 2011)​). Most neoplasias result from alteration of cancer gene              
expression or structure by provirus integration, a phenomenon called oncogenesis by           
insertional mutagenesis (see below). The penetrance of neoplasias is especially high when            
individuals are infected congenitally which evokes immunological tolerance to the virus.           
Under such conditions, there is no or very low immune reaction against the virus and high                
provirus load builds up in the blood and other tissues. If an individual is infected               
post-hatching, when the immune system is fully developed, viremia is only transient and is              
usually followed by anemia. 
An example of subgroup-specific disease is osteopetrosis, characterized by osteoblasts          
hyperproliferation and enlarged bones, sometimes coupled with stunting ​(Powers et al. 1988;            
Ralph E. Smith, Davids, and Neiman 1976; R. E. Smith and Morgan 1984; Fritzsche and               
Bahnemann 1969; Schmidt and Smith 1981)​. Osteopetrosis is typical of B subgroup ALVs,             
though some A subgroup viruses were also connected with this disease ​(Barbosa et al.              
2010)​. Another unique feature of osteopetrosis is that, contrary to other analyzed            
ALV-induced tumors, it is not caused by insertional mutagenesis ​(Robinson et al. 1983)​. 
A further example of subgroup-specific disease is subgroup J-induced myelocytomatosis          
which had a huge impact on poultry farming just recently ​(D. Zhou et al. 2019; Venugopal et                 
al. 2000)​. The prototype strain, HPRS-103 ​(Payne 1998)​, emerged after a series of             
recombinant events between exogenous ALVs and ev/J loci of the EAV family of             
endogenous retroviruses ​(Melanie A. Sacco et al. 2004; M. A. Sacco et al. 2000; Bai, Payne,                
and Skinner 1995)​. Such recombinations seem to occur frequently, as new isolates are             
being found regularly and show no kinship with the previously reported ones ​(Su et al. 2020;                
Sun and Cui 2007; Melanie A. Sacco et al. 2004)​. 
Subgroup K was established upon isolation of three strains (JS11C1-3) of Luhua            
chicken-based solely on the sequence of the envelope glycoprotein ​(Cui et al. 2014; Wang              
X., Zhao, and Cui 2012)​. The virus emerged as a result of multiple recombinations between               
exogenous and endogenous viruses and, so far, it exhibits poor replication ability ​(Su, Li,              
Cui, et al. 2018)​. No data are available about its receptor usage or host range and only little                  
is known about its pathogenicity ​(Liang et al. 2019; Zhao et al. 2018b)​. 
Subgroup of low risk to poultry: E 
Subgroup E represents the principal type of chicken endogenous proviruses, named ev            
family ​(Astrin et al. 1980)​. Although most of the endogenous proviruses of ev type are               
defective, some are not and have the potential to produce exogenous virus. However, the              
produced viruses have only quite a low pathogenicity as their activity is hampered by a weak                
enhancer and promoter in the LTR ​(Crittenden et al. 1980; Cullen, Skalka, and Ju 1983;               
Jenkins and Cooper 1980)​. Nevertheless, the presence of ev locus encoding functional virus             
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was shown to result in reduced production of eggs ​(Gavora et al. 1991)​. Even the presence                
of defective endogenous proviruses has adverse effects. Through evoking tolerance to           
antigens shared between ALVs, endogenous proviruses mitigate the immune response to           
exogenous ALVs which makes the animal more sensitive to ALV infection and aggravates             
the outcome ​(Crittenden, Smith, and Fadly 1984; Gavora et al. 1995; Crittenden, Fadly, and              
Smith 1982)​. Importantly, subgroup E viruses were detected in vaccines produced in chicken             
embryos ​(Barbosa, Zavala, and Cheng 2008; Fadly et al. 2006) which brought up concerns              
about their possible pathogenicity. 
Subgroups of no risk to poultry: C, D, and F to I 
ALVs of subgroups C and D have not been found in the poultry flocks on farms, and for the                   
present, they thus do not inflict any damage. They are represented by two laboratory strains               
of RSV: Prague C and Schmidt-Ruppin D ​(Sandelin and Estola 1975) which provided             
valuable data concerning viral evolution, replication mechanisms, and pathogenicity.         
Subgroup C induces stunting in infected chickens ​(Carter and Smith 1984)​, while subgroup             
D was found to infect and transform some mammalian cell lines and induce tumors in               
newborn hamsters ​(Diglio, Wolfe, and Meyers 1983)​. 
Subgroup F, represented by RPV (ring-necked pheasant virus), originally emerged as a            
recombinant of chicken exogenous virus and pheasant endogenous loci ​(Fujita et al. 1974;             
Hanafusa and Hanafusa 1973)​. Neoplastic diseases such as lung angiosarcomas are           
induced by this subgroup and cytotoxicity was observed ​in vitro ​(Simon, Smith, and Hayward              
1984; Simon et al. 1987; Weller, Joy, and Temin 1980)​. However, much like C and D                
subgroups, subgroup F has not been detected in the poultry on farms. 
Subgroups G, H, and I are a group of endogenous viruses isolated from non-junglefowl              
members of genus ​Galliformes​. Prototype viruses are ​GPV from Golden pheasant -            
subgroup G ​(Hanafusa et al. 1976)​, ​(Tal et al. 1977; Fujita et al. 1974)​, RAV-62 from grey                 
partridge - subgroup H ​(Hanafusa et al. 1976)​, and GQV from Gambel's quail - subgroup I                
(Troesch and Vogt 1985)​. They were isolated as recombinants with exogenous Bryan            
high-titer strain of Rous sarcoma virus (BH-RSV), a virus lacking the env gene, which makes               
it dependent on a helper envelope glycoprotein for spreading. After BH-RSV infection of             
non-junglefowl embryonic fibroblasts followed by irradiation, PEG treatment, or         
spontaneously, recombinant viruses were arising that carried the newly acquired env.           
Partition into G, H and I subgroups was based solely on the host range and interference with                 
other subgroups. Basically, no data concerning their sequences or pathogenicity are           
available ​(Purchase et al. 1977)​. Subgroup G was also shown to be non-ALV later on ​(Chen                





In the case of enveloped viruses, the term viral receptor is reserved for the host surface                
molecule triggering, through physical interaction, irreversible changes in the envelope          
glycoprotein resulting in virus anchorage to the host membrane and virus entry into the cell               
(Walther Mothes et al. 2000)​. Some retroviruses need the simultaneous binding of multiple             
different molecules; an example is HIV which requires one major receptor (CD4) and one of               
two alternative coreceptors (CCR5 or CXCR4) differentially expressed on CD4+          
T-lymphocytes and some nonlymphoid cell lineages ​(Deng et al. 1996; Broder and Dimitrov             
1996)​. In most cases, however, including all studied ALV receptors, a single molecule             




Figure 3.: ALV receptors 
Depicted are receptors used by ALV to enter the host cells: Tva950 and Tva800, 
transmembrane and GPI-anchored forms of Tva receptor used by A subgroup, Tvb receptor 




Tva, the ALV-A receptor, was recently shown to be a cellular receptor for the transcobalamin               
II/B12 complex (Krchlíková, unpublished data). Its LDL-like structure defined by multiple           
cysteine bridges across the binding domain is crucial for virus entry as some variants or               
receptors lacking cysteine bridges render host cells resistant to infection ​(Rong and Bates             
1995; Bélanger, Zingler, and Young 1995)​. The receptor is expressed in two forms, longer              
membrane-spanning form TVA950 and shorter GPI-anchored form TVA800 ​(Bates, Young,          
and Varmus 1993)​. The virus can enter the cell via both forms, though some studies have                
shown differences in virus-receptor interaction and in the following pathways used for            
internalization ​(Narayan, Barnard, and Young 2003)​. Both forms are present in all tissues             
(Merkin et al. 2012; Barbosa-Morais et al. 2012)​. 
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As mentioned before, the binding site for the virus is dispersed through the cysteine-rich              
region, with the crucial role of W48 of the DEW motive ​(Zingler and Young 1996)​. As                
tryptophan is frequently associated with virus entry, W33 was also investigated, but its             
mutations showed no effect on virus entry ​(Contreras-Alcantara, Godby, and Delos 2006)​.            
W48 is certainly not the sole determinant of virus entry since some species are resistant to                
ALV-A while W48 in Tva is untouched. Experiments ​(Melder et al. 2015)​) based on swapping               
parts of quail and chicken Tva suggest that residues E14, F16, R22, L31, and L34 are also                 
important and possibly participate in forming a pocket-like binding site. 
Tvb receptor 
Based on sequence homology, the Tvb receptor was categorized as a member of the tumor               
necrosis factor superfamily. Although homology does not necessarily imply analogical          
physiological function, the fact that subgroup B has a tendency to trigger apoptotic pathways              
suggests that the death domain at the cytoplasmic terminus of Tvb is functional and may be                
activated by binding of the virus ​(Melder et al. 2015; J. Brojatsch et al. 1996)​. The                
extracellular terminus contains three cysteine-rich domains (CRD1-3) crucial for virus entry           
(Heather B. Adkins, Brojatsch, and Young 2000)​. Receptors are ubiquitous in all tissues. 
Tvb is exceptional among ALV receptors by being used by three different subgroups: B, D,               
and E. The interaction shows a non-reciprocal interference pattern - while infection by B or D                
subgroups prevents superinfection by all three subgroups, infection with the E subgroup            
interferes only with superinfection by the E subgroup ​(Melder et al. 2015; J. Brojatsch et al.                
1996; E. J. Smith et al. 1998; H. B. Adkins et al. 1997)​. To explain this phenomenon, the                  
existence of two different isoforms of Tvb was postulated and confirmed. The isoforms,             
called receptor type 1 and type 2, are produced from the same gene ​(Heather B. Adkins,                
Blacklow, and Young 2001)​. Type 1 serves as a receptor for all three subgroups while type 2                 
is specific for B and D. Thus, env B and D appear to downregulate both forms of the receptor                   
whereas env E leaves form 2 available for ALV-B and -D entry. 
It was later demonstrated that the epitope used by subgroup B is a 15-amino acid peptide                
contained within CRD1, positions 32-46, which, when expressed alone, is sufficient to            
promote virus binding and fusion ​(Knauss and Young 2002)​. Amino acid residues L36, Q37,              
L41, and Y42 were shown to be crucial for virus binding and entry. On the other hand,                 
amino-acid residues necessary for subgroup E entry are Y67, N72 and D73 contained within              
CRD2 ​(Knauss and Young 2002; Klucking and Young 2004)​. CRD1 and CRD2 are present              
on both forms of the receptor; the nature of the differences between the isoforms was not                
elucidated, having the same apparent size and the possibility of different glycosylation was             
not ruled out ​(Knauss and Young 2002)​. 
Tvc receptor 
According to sequence homology, the Tvc receptor belongs to the butyrophilin family, a             
subclass of the immunoglobulin protein superfamily; its physiological role in chicken is still             
unclear ​(Elleder et al. 2005)​. The receptor is present in cells of the immune system. Tvc                
contains two extracellular immunoglobulin-like domains, IgV and IgC, and one cytoplasmic,           
likely protein-binding domain, denominated B30.2/SPRY domain. The domain responsible         
for interacting with the env C glycoprotein is IgV, with at least two aromatic amino acid                
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residues, W48 and Y105, being critical for efficient ALV-C infection ​(Munguia and Federspiel             
2008)​. 
Tvj receptor 
The Tvj receptor was identified as sodium/hydrogen exchanger 1 (NHE1), an ubiquitously            
expressed integral membrane protein controlling cytosolic pH and cell volume ​(Chai and            
Bates 2006)​. Unlike other known ALV receptors, Tvj is multiple membrane-spanning           
proteins. 
The region responsible for env J binding and ALV-J entry into the cell is the extracellular                
loop 1 (ECL1) while an ECL1-derived peptide containing amino acid residues 28 to 39, when               
expressed alone, is sufficient to promote virus entry ​(Guan et al. 2017)​. It was demonstrated               
that residues A30, V33, W38, and E39 are crucial for virus binding. The importance of W8                
was highlighted by the fact that multiple species substituted this residue to gain resistance to               
the subgroup J virus while preserving the physiological function of NHE1 ​(Reinišová et al.              
2016)​. 
Unknown receptors (F-I) 
To this day, receptors used by F, G, H, and I subgroups remain unknown. As those                
subgroups cause no economic losses, no attempts to identify their respective receptors have             
been made so far. 
Nonreceptor molecules interacting with env  
Not all cell surface molecules interacting with env fulfill all attributes of the receptor definition.               
Regularly, the virus makes multiple weak and dynamic contacts with molecules present in             
high numbers on the cell surface (e.g., acidic proteoglycans such as heparan sulfate or              
molecules carrying sialic acid). These molecules (sometimes called adhesion receptors) do           
not trigger env rearrangement and cell entry but facilitate infection by effectively increasing             
the concentration of virions in the proximity of receptors as they limit the virion movement to                
rolling or sliding on the cell surface until they contact the genuine receptor ​(Lehmann et al.                
2005)​. The same mechanism may also retain virions in the tissue where the appropriate              
target cells occur. 
Special and interesting types of molecules interacting with env are so-called soluble            
receptors. These are truncated versions of the receptor containing the env-binding domain            
but missing the transmembrane domain. Some of them retain the ability to induce priming              
(rearrangement leading to activated prefusion state with exposed fusion peptide) after           
binding to env. Primed env then can, without the need of the receptor, start the process of                 
fusion and virus entry whenever the virion contacts the cell surface ​(Damico and Bates              
2000)​. However, since primed env is unstable and tends to undergo further rearrangements,             
it has a limited time to fortuitously encounter the cell surface; docking virions on the cell                
surface by adhesion receptors mentioned above is thus very instrumental. Hence, soluble            
receptors can fulfill the function of full-length receptors though they do not fully comply with               
the definition of the receptor by not being a cell surface molecule. On the other side, soluble                 
receptors that bind env but lost the ability to induce priming can, at sufficient concentration,               
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block the interaction between env and the genuine receptor thus imitating neutralizing            
antibodies ​(S. L. Holmen and Federspiel 2000; Sheri L. Holmen et al. 1999)​. 
Resistant forms of receptors 
Many allelic variants of Tva, Tvb, and Tvj receptors, incapable of mediating virus entry into               
the cells were found both in individual domestic chicken lines and in non-chicken birds              
(Elleder et al. 2004; Klucking, Adkins, and Young 2002; Elleder et al. 2005; Reinišová et al.                
2016)​. Fixation of these variants is an obvious result of the virus-host arms race. Pathogenic               
effects of ALV infection had created selection pressure resulting in segregation of receptor             
alleles with substitutions or indel mutations that had changed the receptor structure or             
expression so that the receptor-virus interaction was abrogated or impaired. 
Ideally, from the point of view of the host, the newly formed virus-resistant allele should               
preserve its cellular function. Indeed, no harm to both animals and cell lines seems to be                
inflicted by mutations that created virus-resistant receptor variants such as C40T substitution            
in the cysteine-rich region of Tva ​(Elleder et al. 2004)​, C125S substitution in the cysteine-rich               
region of Tvb ​(Reinisová et al. 2008) or either deletion or substitution of W38 amino acid                
residue in Tvj ​(Kucerova et al. 2013)​. 
In some virus-resistant alleles, however, substitutions or indel mutations changed the           
reading frame and/or created a premature stop codon close to the beginning of the coding               
sequence, thus most likely totally abolishing all gene functions. Examples are the            
ALV-A-resistant 7​2 cell line, where the Tva gene is disrupted by 4-bp insertion in exon 1                
(Elleder et al. 2004) or in ALV-B-resistant chickens with C172 codon of Tvb mutated to a                
premature stop codon ​(Klucking, Adkins, and Young 2002)​. Even animals with such a gene              
in a homozygous state are perfectly healthy suggesting that the functions of the protein are               
redundant and can be substituted by other proteins. 
A special type of variant was observed for Tva: deletions in the intron region led to low levels                  
of properly spliced mRNA and low levels of the receptor on the cell surface. Decreasing the                
levels of the protein was sufficient to render cells resistant to the virus; loss of the cellular                 
functions was considered but not proven ​(Reinišová et al. 2012)​. 
Evolution of ALV env glycoproteins and arms race between the virus and the cell 
The sequence comparison of env A, B, C, and E indicates that they have a common                
predecessor. That, together with the existence of receptor variants resistant to ALV of the              
relevant subgroups, suggests that ALV diversification into several subgroups was a step in             
the continual virus-host arms race, a response of the virus to the effort of the host to escape                  
virus infection by segregating resistant receptor alleles. To bypass the loss of a functional              
receptor, the virus was forced to change its receptor specificity by adapting to changes in the                
binding pocket on the receptor, by switching to another epitope on the same molecule, or               
even by switching to a new receptor. When Mark Federspiel´s group tested the proficiency of               
multiple ALV-A isolates with substitutions and indel mutations in env to recognize different             
variants of the Tva receptor, they found that some receptors, though nonpermissive for some              
env variants, are still used by other env variants ​(Melder et al. 2015) and suggested this is a                  
manifestation of past arms races. Earlier, they even selected variants of ALV-A with             
mutations of the hr1 region, that enabled the virus to infect cells pre-infected with the same                
subgroup ​(S. L. Holmen and Federspiel 2000; Melder, Pankratz, and Federspiel 2003)​.            
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Since they observed a very low but detectable interference between these ALV-A-derived            
variants and ALV-B or ALV-C subgroups, they suggested that selected variants of ALV-A             
acquired the ability to interact with Tvb or Tvc ​(Mark J. Federspiel 2019)​. This phenomenon               
is not limited to ALV-A as a similar effect of mutations in env was observed for ALV-B ​(Yin et                   
al. 2019)​. All the above facts point to the same notion: to bypass the loss of a functional                  
receptor, the virus was forced to change its receptor specificity by adapting to changes in the                
binding pocket on the receptor, by switching to another epitope on the same molecule or by                
switching to a new receptor. 
There is yet another (and maybe the most efficient) way how the virus can deal with the loss                  
of functional receptors on cells. Some env mutations apparently decrease the energy barrier             
for priming thus destabilizing the envelope glycoprotein (naturally semi-stable already before           
acquiring the mutation) and capacitating it to switch into an activated prefusion state without              
the need of the receptor. Viruses mutated in this way are able not only to enter the cells that                   
lost the functional receptor but also infect cells from other, previously nonpermissive species             
including mammals ​(Rainey et al. 2003; Taplitz and Coffin 1997; Kawai et al. 1989)​.  
Receptor-independent entry, however, brings negative side effects, namely decreased virus          
viability as the destabilized env has a short lifespan and is temperature-sensitive ​(Bova-Hill,             
Olsen, and Swanstrom 1991)​. Thus, env destabilization might be only a transient solution             
that creates an opening for further adaptation after which the env may be stabilized again. 
This group of viruses, often called viruses with extended host range, might be responsible              
for interspecies virus transmissions. Such enterprise is, however, much more complicated           
than just tailoring env to a new receptor the virus must make many more adjustments, e.g.,                
readjust different regulatory sequences (enhancer and promoter within its LTR, sequences           
influencing splicing, transport, etc.) and take measures to evade different restriction factors            
and provirus silencing in non-avian species ​(Brown and Robinson 1988; Searle et al. 1984)​. 
The extended host range provided by destabilization of envelope glycoprotein is not specific             
for ALV. It was also observed in other groups of retroviruses such as HIV ​(Keller et al. 2018)                  
and in distant viruses such as the measles virus ​(Jurgens et al. 2015)​. 
In the past, attempts to eradicate pathogenic ALV strains from poultry farms were done by               
killing off the whole flocks whenever ALV infection was detected and replacing them with a               
new cohort of ALV-negative hens and cocks ​(Spencer et al. 1977)​. Recently, the             
CRISPR/Cas9 system was successfully used to generate chickens with a mutation in the Tvj              
gene that prevents infection with ALV-J ​(Koslová et al. 2020)​. The same procedure should              
be easy to employ for any ALV subgroup. However, examples of arms races discussed              
above raise the question about the endurance of nonpermissiveness based only on a single              
amino acid change in the receptor. Due to a very high mutation and recombination rate of                
retroviruses, the virus adjustment may not take a long time. Indeed, comparative analysis of              
recently emerged subgroup J and postulated subgroup K showed a high mutation rate of env               
sequences ​(P. Wang et al. 2018; Pan et al. 2012; X. Li et al. 2016; Zhao et al. 2018a)​. 
In the light of the above facts, understanding of retroviral envelope glycoprotein interactions             
with respective receptors including their evolution during the virus-host arms race is of             




Mechanisms of retroviral tumorigenesis 
Retroviruses can induce tumorigenesis by several mechanisms each having very distinct           
hallmarks. Only the two of them were observed with ALVs so far. 
The first mode of action is carried out by retroviruses encoding a viral version of the cellular                 
proto-oncogene, collectively called oncogene-transducing retroviruses. A great many genes         
were taken over this way such as src ​(Barnekow et al. 1981)​, myb ​(Radke et al. 1982)​, myc                  
(Enrietto 1989) and erbA/B ​(Graf and Beug 1983) by alpharetroviruses, mos ​(Stoica 1994)​,             
ras ​(Rothstein et al. 1985) and fes ​(Groffen et al. 1983) by gammaretroviruses to name just a                 
few of the most familiar ones. Tumors induced by these viruses arise shortly after infection               
and have a polyclonal origin as the tumor develops from many independently infected cells.              
It must be emphasized that, outside the laboratory, transducing retroviruses do not spread             
and do not survive (a consequence of their excessive pathogenicity and replication            
incompetence) and each isolate has arisen de novo. 
The second mechanism (the most typical and frequent one) is the insertional mutagenesis,             
already mentioned in the chapter on pathogenesis. This process takes a longer period of              
time since it requires infection of a huge number of cells until a cancer gene is hit by provirus                   
integration in one or a few cells. Resulting tumors are in principle clonal and are               
characterized by the presence of a provirus in the same locus in independent tumors              
(so-called common site of integration harboring a cancer gene ​(Kung and Vogt 2012)​). 
The third mechanism is connected to the side effects of viral accessory genes that regulate               
gene expression - transactivating proteins like Tax of HTLVs (human T-lymphotropic virus)            
(Millen et al. 2020) or non-coding RNAs, such as of AS1 locus of BLV (bovine leukemia                
virus) ​(Safari et al. 2020)​. Tumor induction by these proteins is characterized by low              
penetrance and long latency. The tumors are clonal, probably due to the requirement of the               
further infrequent event to happen. 
Finally, the fourth mechanism of retroviral oncogenesis implicates one of the basic retroviral             
genes: the env. Solid evidence accumulated showing that the envelope protein of some             
retroviruses possesses the ability to transform infected cells. In the following chapter the             
respective viruses will be listed and molecular details of this process, where known, will be               
reviewed. 
Envelope glycoproteins as tumorigenic agents 
Ovine pulmonary carcinomas (OPA) that manifest themselves by dyspnea in herded sheep            
and goats were first observed in the nineteenth century in South Africa ​(Sharp et al. 2008)​.                
The origin of this condition, called jaagsiekte (compound of African words for driving, jaagt,              
and sickness, ziekte), was discovered much later and named Jaagsiekte sheep retrovirus            
(JSRV, ​(Palmarini et al. 1999)​. JSRV does not carry any transduced oncogene. Insertional             
activation was excluded due to low expression of the virus and the rapid onset of OPA in                 
infected animals. The alternative open reading frame inside the pol gene (orf-x) with the              
unknown function was shown to be dispensable for infection and transformation both in vitro              
and in vivo ​(N. Maeda et al. 2001)​. Thus, attention turned to possible oncogenic properties of                
either gag, pol, or env genes. It was found that env, when expressed alone, was able to                 
transform several rodents, human, and chicken cell lines, ​(N. Maeda et al. 2001)​. The              
dominant and crucial role of JSRV-env in tumorigenesis was then demonstrated in vivo: a              
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replication-defective vector expressing JSRV env gave rise to lung tumors in sheeps            
(Caporale et al. 2006)​; similarly, an AAV-6 (Adeno-associated virus 6) vector expressing            
JSRV env induced lung tumors in Rag-2 knockout mice ​(Wootton et al. 2006)​.  
Molecular mechanisms of JSRV env tumorigenic activity are still unsure. Comparison of            
exogenous JSRV with its endogenous non-tumorigenic forms revealed differences in at least            
67 amino acids, located in the membrane-spanning domain and the cytoplasmic tail            
(Palmarini et al. 2000)​. One of the most striking differences was the presence of tyrosine at                
position 590 (Y590) in exogenous JSRV env. Mutations of Y590 abolished both            
transformation of rodent cells and OPA induction in mice, ​(Palmarini et al. 2001; Cousens et               
al. 2007)​. Since Y590 is part of the YxxM motif which, in a phosphorylated state, represents                
a putative binding motif for the SH2 domain of P3Ik regulatory subunit p85, it was suggested                
that P3Ik/Akt signaling pathway is involved in JSRV-driven tumorigenesis ​(Palmarini et al.            
2001)​. However, although Akt is active (albeit inconsistently) in tumor cells, no            
phosphorylation of Y590 or binding to p85 was observed ​(Liu, Lerman, and Miller 2003)​.              
Moreover, ​JSRV is able to transform p85 knockout mice-derived cells ​(Zavala et al. 2003)​.              
Involvement of signaling through MAPK pathways was also considered as a high activity of              
Ras, MEK, and MAPK was observed in transformed cells and OPA ​(Naoyoshi Maeda et al.               
2005)​, and inhibitors of Ras and MEK1/2 abolished transformation of rodent cell lines. Some              
studies also draw attention to the possible importance of Src kinase, Hsp90, and Rac1 in               
JSRV driven transformation ​(Hull and Fan 2006; Varela et al. 2008; Naoyoshi Maeda and              
Fan 2008)​. None of the above observations, however, points to direct interconnection with             
env protein. 
A more promising hypothesis came with the discovery of Hyal-2 (hyaluronidase-2) being the             
cellular receptor recognized by the JSRV env. ​(Rai et al. 2001)​. Hyal-2 functions as a tumor                
suppressor that binds RON/STK receptor tyrosine-protein kinase and interferes with its           
signaling ​(Ronsin et al. 1993)​; its deletion is often observed in human lung carcinomas.              
Thus, a role of JSRV env-Hyal-2 interaction in tumorigenesis was proposed ​(Rai, DeMartini,             
and Miller 2000) and the following scheme was suggested: virus-driven down-regulation of            
Hyal-2 results in stronger signaling from RON, which in turn activates both PI3k/Akt and              
Ras/Raf/MEK/MAPK signaling pathways ​(Danilkovitch-Miagkova et al. 2003)​. However, this         
scheme is obviously not universal since JRSV transforms mouse cells despite the fact that              
murine Hyal-2 does not bind JSRV env ​(Liu et al. 2003)​. Furthermore, it was shown RON                
can bind not just Hyal-2, but also JSRV and MuLV envs, making the whole story even more                 
complicated ​(Varela et al. 2006)​. 
Interestingly, a short splicing variant of env, called Rej, was discovered recently and shown              
to be indispensable for JSRV gag synthesis in vitro essays The final functional product of               
Rej is its signal peptide released by a signal peptidase during Rej translocation into the               
endoplasmic reticulum. At least a proportion of it escapes from ERAD (Endoplasmic            
Reticulum-Associated Degradation) and is transported to the nucleus. However, since the           
same signal peptide is also released from the major full-length form of env, the Rej variant                
maybe just inconsequential curiosity that does not significantly increase the amount of active             
product. In any case, the signal peptide is required for JSRV replication but does not seem                
to be involved in oncogenesis ​(Hofacre, Nitta, and Fan 2009)​. 
A similar way of tumorigenesis was observed with ENTVs (Enzootic nasal tumor viruses, a              
close relative of JSRV). ENTVs induce ENA (enzootic nasal adenocarcinoma) in the sheep             
(ENTV-1) and goats (ENTV-2) ​(De las Heras et al. 2003)​. Similar to JSRV env, ENTV-1 and                
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ENTV-2 envs transform rodent cells and activate MAPK and PI3k/Akt signaling pathways            
(Palmarini et al. 2000; Alberti et al. 2002; Liu and Miller 2005; Naoyoshi Maeda and Fan                
2008; Naoyoshi Maeda et al. 2020)​. Though there are significant differences between            
cytoplasmic tails of JSRV and ENTV env, Y590 mentioned above is also present in ENTV,               
and mutation of this amino acid also reduces the transformation ability of the env. Interacting               
partners and molecular mechanisms underlying tumorigenesis were not established.  
The ability of another betaretrovirus, MMTV (mouse mammary tumor virus) to induce            
mammary adenocarcinomas via insertional mutagenesis of cellular proto-oncogenes has         
been known for a long time ​(Bittner 1936; Nusse and Varmus 1982)​. However, a later               
demonstration that MMTV env alone can transform murine and human cells ​(Katz et al.              
2005) called this simple notion into question. MMTV env SU contains a putative ITAM              
(immunoreceptor tyrosine-based activation motif), Yxx(L/I)x​6-8​Yxx(L/I) that could potentially        
play a role in the transformation ​(Ross et al. 2006)​. Mutations of either tyrosine of this motif                 
reduced transformation abilities both in vitro and in vivo, 
MMTV env was also reported to bind mouse TLR4 (toll-like receptor 4), a sensor of               
pathogen-associated molecular patterns ​(Rassa et al. 2002)​. Later on, however, it became            
clear that the interaction of MMTV with TLR4 is mediated by the bacterial LPS              
(lipopolysaccharides) bound to the LPS receptors that have been incorporated into the            
MMTV envelope ​(Wilks et al. 2015)​. In any case, TLR4 stimulation by MMTV leads to the                
production of ​immunosuppressive cytokines and blockage of the antiviral response; no ​role in             
the MMTV-driven carcinogenesis is presumed.  
Similarly to JSRV, a short splicing variant of env, in the case of MMTV called Rem, was                 
found. In every way, Rem seems to be an equivalent of Rej in JSRV, including doubts about                 
the importance of this splicing variant (Buyn 2010 - PNAS).  
All the viruses discussed above have the ability to induce tumorigenesis via a fully functional               
envelope glycoprotein. Highly oncogenic F-SFFV (Friend spleen focus-forming virus), on the           
other hand, codes for a recombinant, shortened, and defective env. The env contains a 195               
amino acid deletion in the middle part that connects the amino terminus of SU with the                
carboxy terminus of TM; the deletion eliminates SU/TM cleavage site. The TM part,             
moreover, lacks the whole cytoplasmic tail due to a single base insertion and premature              
termination. The SU part best aligns to dual tropic MCF (mink cell focus-forming virus) which               
itself is a recombinant of exogenous ecotropic MuLV with endogenous dual tropic MuLV,             
while the TM part is derived from ecotropic F-MuLV (Friend murine leukemia virus)             
(Amanuma et al. 1983; Wolff, Scolnick, and Ruscetti 1983; Clark and Mak 1983)​. 
F-SFFV together with its anticipated parents were components of the Friend virus complex             
isolated in 1957 from a mouse injected with Ehrlich mouse carcinoma cells ​(Friend 1957)​.              
The complex, as well as the mixture of F-MuLV (as a helper) with F-SFFV or with a retroviral                  
vector expressing only SFFV env, induced rapid-onset erythroleukemia in mice ​(Wolff and            
Ruscetti 1988)​. Development of erythroleukemia in transgenic mice expressing only SFFV           
env definitely proved that the env is sufficient for leukemogenesis and does not require other               
parts of SFFV nor the helper virus ​(Aizawa et al. 1990)​. A comparison of many deletions and                 
recombination variants formed during SFFV passaging showed that the TM part, not the SU              
part, of SFFV env, is crucial for leukemogenesis ​(Gomez-Lucia et al. 1998)​. 
The search for SFFV env interaction partners revealed that it binds directly to the EpoR               
(erythropoietin receptor). This interaction results in activation of signaling molecules typical           
for a response to erythropoietin: JNK (c-Jun N-terminal Kinase), Stat5 (Signal Transducer            
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and Activator of Transcription 5), PKC (Protein Kinase C), Ras/Raf/MEK/MAPK pathway,           
and PI3k/Akt pathway. This demonstrates that SFFV env mimics the action of erythropoietin             
which results in the proliferation of erythrocyte precursors ​(Ohashi, Masuda, and Ruscetti            
1996, 1995; Muszynski et al. 1998)​. Only a small fraction ​of SFFV env (less than 5%) is                 
successfully processed and is displayed on the cell surface, and none is packaged into              
virions. Though ER-retained majority of SFFV env makes on-site complexes with EpoR, only             
interaction on the cell surface activates appropriate signaling cascades. Ternary complexes           
SFFV env-EpoR-Epo form on the surface of erythroid cells when both Epo and SFFV are               
present, suggesting that different epitopes on EpoR are occupied by the two ligands ​(Ferro              
et al. 1993)​. 
 
 
Figure 4.: Envelope glycoproteins involved in oncogenesis 
Brief scheme of envelope glycoproteins of SFFV (A), MMTV (B), JSRV, and ENTV (C) and               
their possible interaction partners participating in env-driven oncogenesis ​(adapted from          






Envelope glycoprotein with unknown yet essential role in tumorigenesis 
Among ALVs, two strains carry env with potent oncogenic activity: AHV (Avian hemangioma             
virus) and MAV (Myeloblastosis-associated virus). Though chicken retroviruses contributed         
enormously to the whole field of oncogenesis (discovery of the first cellular protooncogene -              
src - and discovery of the phenomenon of oncogenesis by insertional mutagenesis – myc),              
today’s researches became somewhat uninterested in chicken models and the two ALV            
strains were little studied. 
AHV generates vascular tumors in about 30 % of infected birds 3-10 months after infection               
and induces anchorage-independent growth of monkey and murine cells ​(Burstein et al.            
1984; Alian et al. 2000)​. Its env retains oncogenic ability when expressed alone in a               
retroviral vector; even the SU alone is transforming (though on a reduced level). AHV virus               
as well as purified AHV SU are also able to induce a significant CPE (cytopathic effect) in                 
chicken cells ​(Resnick-Roguel et al. 1989; Sela-Donenfeld et al. 1996)​. There is no             
knowledge of underlying mechanisms. 
The other virus, MAV-2, was originally isolated by endpoint dilution from the complex viral              
stock AMV BAI A (Smith, R. E., and C. Moscovici. 1969) where it served as a helper of                  
defective c-myb-transducing acutely oncogenic virus AMV (Avian Myeloblastosis Virus).         
MAV-2 proved to be a non-defective B-subgroup virus with a strong tendency to induce both               
nephroblastomas and osteopetrosis (a disease characterized by hyperproliferation of         
osteoblasts ​(Souza et al. 1980; R. E. Smith, Davids, and Neiman 1975)​. MAV variants with               
different potential to promote osteopetrosis, from low (less than 10%) to very high (100 %),               
have been isolated (Karafiát, unpublished data).  
Experiments aimed to identify osteopetrosis-inducing determinants via the construction of          
chimeric viruses led to the conclusion that both env and LTR were involved in the               
osteopetrosis induction ​(Joliot et al. 1993)​. The importance of the TM region rather than the               
SU conforms with the observation that osteopetrosis potential is not limited to B-subgroup,             
as documented, e.g., by MAV-1-like virus responsible for osteopetrosis outbreak in Costa            
Rica in 1986 ​(Barbosa et al. 2010)​. As in the case of AHV, mechanisms underlying this                
disease are not known, except that very high levels of unintegrated MAV proviruses in              






The envelope glycoproteins play a crucial role in the life cycle of enveloped viruses including               
retroviruses. The first steps of virus entry start with receptor recognition, assisted by             
interactions with other adhesive molecules on the cell surface, followed by the fusion of viral               
and cell membranes. The envelope glycoprotein is also an important template of retrovirus             
evolution because its endogenous expression prevents subsequent entry of superinfection          
virions of the same genus. Thus any changes in receptor-binding regions constitute an             
advantage for the new generation of viruses. Although it is widely acknowledged that             
retroviruses evolve through cross-species transmission and host range extension, the exact           
mechanism of receptor shift is still unclear. 
 
Recently, a new group of avian leukosis virus emerged, denoted ALV-K solely on the              
sequence divergence to other subgroups. To support these findings, host range           
examination, interference analysis, and possibly receptor identification remain to be done.           
Therefore, we decided to check if JS11C1 represents a new subgroup of avian leukosis              
viruses and explore this recent example of env-receptor co-evolution. 
 
Although such analysis of the newly emerging subgroup provides a great chance to the              
understanding of virus evolution, the information about shifting the receptor specificity might            
be missing due to the fully adapted envelope. Therefore, we resorted to the traditional model               
in our laboratory, a hamster cell line derived from Rous sarcoma virus-induced tumors.             
Mammalian cells do not support RSV replication and lack any molecule which might serve              
as a receptor for alpharetroviruses. Therefore, we investigated RSV provirus in the H20 cell              
line from the point of view of env-receptor co-evolution. 
 
The envelope glycoprotein was also reported to be crucial for virus pathogenesis in the case               
of beta- and gammaretroviruses. Similarly, chicken osteopetrosis is promoted upon infection           
of certain ALV strains, e.g., MAV-2.O, and involvement of the envelope glycoprotein has             
been suggested. Having available the standard myeloblastic strain of MAV and its            





Materials and methods 
Preparation of embryo fibroblasts and cell culture 
Embryo fibroblasts of domestic chicken, ducks, and wild galliform species were prepared as             
described earlier ​(M. J. Federspiel and Hughes 1997)​, from embryos in the middle of              
incubation, i.e., 11 or 12 days postfertilization. Embryonated eggs were obtained as follows:            
northern bobwhite (​Colinus virginianus​) and red jungle fowl (​G. gallus subsp. ​murghi​) from             
South Bohemia Zoological Gardens (Hluboká nad Vltavou, Czech Republic), California quail           
(​Callipepla californica​), Gambel’s quail (​Callipepla gambelii​), silver pheasant (​Lophura         
nycthemera​), white-crested kalij pheasant (​Lophura leucomelanos subsp. ​hamiltoni​), and         
gray jungle fowl (​Gallus sonneratii​) from the AVES Farm (Košice, Czech Republic), guinea             
fowl (​Numida meleagris​), turkey (​Meleagris gallopavo​), and chukar (​Alectoris chukar​) from           
the University of Veterinary and Pharmaceutical Science (Brno, Czech Republic), gray           
partridge (​Perdix perdix​), common ringed-neck pheasant (​Phasianus colchicus​), and         
Reeve’s pheasant (​Syrmaticus reevesii​) from the Židlochovice Forest Enterprise         
(Židlochovice, Czech Republic), and Mrs. Hume’s pheasant (​Syrmaticus humiae​) from          
Fasanerie Christian Möller (Erfurt, Germany). Chicken embryo fibroblasts were prepared          
from inbred lines CB, WA, L15, H6, and M and duck embryo fibroblasts from Khaki               
Campbell, which were maintained at the Institute of Molecular Genetics (Prague, Czech            
Republic). All embryo fibroblasts, as well as the permanent chicken cell line DF-1 ​(Himly et               
al. 1998) and the Japanese quail (​Coturnix japonica​) tumor cell line QT6 ​(Moscovici et al.               
1977)​, were grown in a mixture of 2 parts Dulbecco’s modified Eagle’s medium and 1 part                
F-12 medium supplemented with 8% fetal calf serum, 2% chicken serum, and 1×             
antibiotic-antimycotic solution (Sigma), in a 5% CO2 humidified atmosphere at 37°C. 
Construction of RCAS vector with JS11C1 ​env​ gene 
We prepared the K subgroup RCAS vector by replacing the ​env gene in the              
RCASBP(D)GFP subgroup D retrovirus vector ​(M. J. Federspiel and Hughes 1997; Hughes            
2004) with the complete ​env gene of JS11C1 virus. RCASBP(D)GFP transducing the GFP             
reporter gene was digested with KpnI and StuI (both from New England BioLabs), and the               
1,853-bp fragment containing the 3′ end of ​pol and the entire ​env gene was discarded. The                
JS11C1 ​env gene (GenBank accession no. ​KF746200​.1) was synthesized (Integrated DNA           
Technologies) together with adjacent RCAS sequences, including the KpnI and BsaBI sites            
at the 5′ and 3′ ends. Due to an additional BsaBI site present in the ​env coding sequence, a                   
partial KpnI-BsaBI (New England BioLabs) digestion was performed to obtain the 2,120-bp            
fragment, which was then inserted into the RCAS backbone; the resulting vector,            
RCASBP(JS11C1)GFP, was used for virus propagation and infection experiments. 
Construction of RCAS vectors with dsRed fluorescent marker 
The RCASBP(A)dsRed and RCASBP(JS11C1)dsRed vectors used in the superinfection         
experiments were prepared by replacing the ​gfp gene of RCASBP(A)GFP and           
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RCASBP(JS11C1)GFP with ​dsRed-Monomer​. The coding sequence of ​dsRed-Monomer​,        
encoding a monomeric mutant of the fluorescent protein dsRed, was amplified with forward             
(5′-accactgtggcatcgatGGTCGCCACCATGGACAACAC-3′) and reverse   
(5′-ccgtacatcgcatcgatCTCTACTGGFGCCGGAGTG-3′) primers from the    
pDsRed-Monomer-N1 vector (Clontech) and was cloned into ClaI-linearized        
RCASBP(A)GFP and RCASBP(JS11C1)GFP vectors using the In-Fusion HD cloning kit          
(Clontech). The 17-bp overlapping sequences of the forward and reverse primers are shown             
as lowercase letters. 
Virus propagation and FACS assay of virus infection 
All viruses used in this study were propagated by transfection of their respective vector              
plasmid DNA into DF-1 cells using the XtremeGENE transfection reagent (Roche). Virus            
stocks were harvested on day 9 or 10 posttransfection and were cleared of debris by               
centrifugation at 2,000 × ​g for 10 min at 10°C. Aliquoted viral stocks were stored at −80°C.               
Virus titers were determined by terminal dilution, subsequent infection of DF-1 cells, and             
detection of GFP positivity. All RCAS-based retrovirus vectors used in this study reached             
titers of 10​6 IU per ml. The ​in vitro infection of GFP- or dsRed-transducing RCASBP vectors                
was assayed in cultured avian embryo fibroblasts, QT6 cells, or NIL-2 cells. The cells were               
seeded at a density of 5 × 10​4 cells per well in a 24-well plate; 24 h after seeding,                
5 × 10​5​ IU of the virus was added to 0.25 ml medium for 1 h. Two days postinfection, the               
cells were washed in phosphate-buffered saline, trypsinized, pelleted by centrifugation in the            
cultivation medium, and resuspended in Hoechst solution (Sigma). The percentages of           
GFP-positive cells, dsRed-positive cells, and GFP/dsRed-double-positive cells were        
quantitated by FACS analysis using an LSRII analyzer (Becton, Dickinson). 
Ectopic expression of Tva in Syrian hamster NIL-2 cells 
Induction of susceptibility to RCASBP(A)GFP and RCASBP(JS11C1)GFP by ectopic Tva          
expression was shown using Syrian hamster (​Mesocricetus auratus​) NIL-2 cells stably           
transfected with the Tva expression vector ​(Elleder et al. 2005)​. The NIL-2 cell line was               
transfected, using Lipofectamine 2000, with 2 μg of plasmid pTva together with 0.2 μg of             
pMC1neo poly(A) (Stratagene, La Jolla, CA), which contains the neomycin resistance gene.            
The transfected cells were grown for 10 days with G418 (500 μg/ml) to select for neomycin              
resistance. NIL-Tva was isolated as a cell clone from soft agar, expanded, and used for               
infection experiments. 
Preparation of ​tva​ and ​tvb​ knockout DF-1 clone 
We employed the DF-1-​tva​−/− cell clone described previously ​(Koslová et al. 2018) and the              
newly constructed DF-1ΔTvb. Briefly, we used CRISPR/Cas9 genome-editing tools and          
cloned the guide RNA sequences 5′-CCGACTGCTACCCGCTGGAG-3′ and       
5′-GCATCCCCACCAGGAACACG-3′​, matching the second exon of the chicken ​tva gene          
and fourth exon of chicken ​tvb ​gene, respectively, into the single guide RNA cloning              
backbone of the PX458 vector (AddGene vector pSpCas9BB-2A-GFP plasmid 48138). The           
36 
 
resulting construct was transfected into DF-1 cells using Lipofectamine 3000 (Thermo Fisher            
Scientific), according to the manufacturer’s protocol. CRISPR/Cas9 indel activity was          
assayed by T7EI heteroduplex cleavage, and single-cell clones were derived using the            
single-cell sort mode of the Influx cell sorter (Becton, Dickinson). The expanded clones were              
then tested for resistance to RCASBP(A)GFP and frame-shifting deletions in the ​tva            
sequence and for resistance to RCASBP(B)GFP and frame-shifting deletions in the ​tvb            
sequence, respectively.  
Soluble Tva immunoadhesin production and inhibition of virus 
infection 
As a source of the soluble form of Tva receptor, we used the quail Tvas receptor fused to the                   
constant region of a mouse IgG heavy chain, also known as immunoadhesin sTva-mIgG.             
The sTva immunoadhesin was expressed from the RCASBP(B)stva-mIgG vector, containing          
the ​stva-mIgG gene cassette in the ClaI cloning site ​(Sheri L. Holmen et al. 1999)​. The                
RCASBP(B)stva-mIgG vector was a kind gift from M. J. Federspiel (Mayo Clinic, Rochester,             
MN). Stocks of sTva-mIgG immunoadhesin were generated by transfection of          
RCASBP(B)stva-mIgG plasmid DNA into DF-1 cells using the XtremeGENE transfection          
reagent (Roche) and harvesting of the supernatant after 1-week culture of infected cells. The              
supernatant was cleared by centrifugation at 2,000 × ​g for 10 min at 4°C and stored at              
−80°C. The RCASBP(A)GFP and RCASBP(JS11C1)GFP virus aliquots were mixed with          
sTva-mIgG supernatant at 4°C and used for DF-1 cell infection after 30 min of             
preincubation. 
XC and H20 cell line origin 
XC and H20 are rodent tumor cell lines transformed with the PR-RSV-C strain. The rat XC                
cell line harbors several provirus copies per genome ​(Mitsialis et al. 1983)​, whereas the              
hamster H20 cell line possesses only a single provirus ​(Svoboda et al. 1983)​. Both cell lines                
produce either no or negligible infectious virus ​(Geryk et al. 1984; Svoboda et al. 1963)​. The                
XC cell line is derived from a tumor that was induced by inoculation of PR-RSV-C–infected               
chicken tissues into newly born rats ​(Svoboda 1960)​. The H20 cell line was prepared in a                
similar way with the difference that chicken sarcoma tissue induced by XC-RSV, which was              
rescued by transfection from XC cells, was inoculated into newly born Syrian hamsters             
(Geryk et al. 1984)​. 
TM oligomerization assay 
The TM oligomerization assay was performed similarly as previously described ​(Walther           
Mothes et al. 2000; J. G. Smith et al. 2004; Melder et al. 2009)​. The temperature threshold                 
that triggers TM oligomerization was determined by incubating the purified virions in HN             
buffer [10 mM Hepes, 130 mM NaCl (pH 8.0)] at the indicated temperature for 20 min before                 
lysis with Laemmli loading buffer (1% SDS, 10% glycerol, 0.1 M Tris-Cl, pH 6.8, 0.1%               
bromophenol blue, 5% β-mercaptoethanol). The pH of HN buffer with virions was adjusted             
with predetermined volumes of 100 mM Hepes (pH 3.8 or 7.4), and the samples were               
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incubated at room temperature for 30 min. The samples were then neutralized with 1 M Tris                
(pH 7.6 or 9.5), lysed with Laemmli loading buffer, and analyzed by immunoblotting after              
SDS/PAGE in 11% polyacrylamide gels with a rabbit antibody specific for the carboxyl             
terminus of the TM subunit of ASLV Env (1:1,000) ​(Walther Mothes et al. 2000)​. 
Virus liposome binding assay 
The virus liposome binding assay is a modification of the protocol previously described             
(Melikyan et al. 2004)​. A total of 10​5 GFP-transducing units of each virus in 100 µL of                 
cultivation media was incubated with 250 µL of liposomes (5 mM) at 37 °C for 30 min. A total                   
of 350 µL of ice-cold 80% sucrose-PBS was added to the preparation to bring it to 40%                 
sucrose, and 700 µL of this solution was layered on 3.2 mL of 50% sucrose-PBS and                
overlaid with 1 mL of 30% sucrose-PBS and 100 µL of 5% sucrose-PBS. The samples were                
ultracentrifuged at 152,000 × ​g at 4 °C for 2 h. Three 400-µL aliquots followed by one 600-µL                  
aliquot were taken from the air-liquid interphase. The top 400 µL and the last 600 µL                
(fraction above 50% sucrose, called bottom) of each sample were mixed with 5× Laemmli              
loading buffer, boiled for 10 min, and separated in 13% SDS/PAGE. The presence of virions               
was detected by immunoblotting with the anti-ASLV rabbit p27 Antiserum (Charles River            
Laboratories, 1:1,000). 
Statistical Analysis 
We performed Welch ​t test to determine significance of difference in virus infectivity. In              
graphs, significant differences are marked by asterisks (*​P = 0.05–0.01, **​P = 0.01–0.001,             
***​P​ < 0.001). 
Cell cultures 
The chicken fibroblast cell line DF-1, which is free of ASLV-related endogenous (​ev​) loci              
(Himly et al. 1998)​, was obtained from S. Hughes, National Cancer Institute, Bethesda. L15              
cells are primary chicken embryo fibroblasts prepared from 10-d-old embryos of chicken            
inbred line L15, which harbors a mutation introducing a premature stop codon in Tvc              
receptor ​(Elleder et al. 2005)​. Hamster cell line NIL-2 is a spontaneously transformed cell              
line derived from Syrian hamster embryo ​(Diamond 1967)​. NIL-2 cells expressing Tvc            
receptor (NIL-Tvc) were derived from NIL-2 and their preparation was described previously            
(Elleder et al. 2005)​. HEK293 (human embryonic kidney cells) and RPE1-hTERT           
(hTERT-immortalized retinal pigment epithelial cells) were purchased from the American          
Type Culture Collection. DF-1, L15, NIL-2, and NIL-Tvc cells were grown in 1:1 DMEM:F-12              
medium (Life Technologies) supplemented with l-glutamine, 5% calf serum, 1–5% FCS, 1%            
chicken serum, and 10% tryptose phosphate broth (Life Technologies). HEK293 and           
RPE1-hTERT cells were grown in DMEM (Sigma) supplemented with 10% FCS and 1×             
antibiotic–antimycotic solution (Sigma). 
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Virus rescue from H20 cells 
X-irradiated H20 cells were fused with DF-1 by means of PEG as described before (​5​). Virus                
production in culture medium was 5–15 focus-forming units (FFU)/mL 4 d after fusion in              
contrast to untreated, treated, or self-fused H20 cells, which produced no infectious virus.             
The virus was then replicated in DF-1 cells to ∼10​5 FFU. The viral particles were               
concentrated by ultracentrifugation through a 25% sucrose cushion at 32,000 rpm for 2 h in               
a Beckman SW38 rotor. 
DNA extraction and RSV ​env​ gene amplification 
The genomic DNA was isolated by phenol-chloroform extraction from the XC, H20, or             
XC-RSV–infected DF-1 cells. The RSV ​env gene was amplified using the forward primer             
PolEnd_fw (5′-TTTGGGTACCCTCTCGAAAAGT) and reverse primer EnvEnd_StuI_rv      
(5′-ACAGGCCTTTTGCATCTTCCTGTATTCAGTA). The following PCR conditions were      
used: 98 °C for 30 s, 36 cycles of 98 °C for 15 s, 65 °C for 30 s, and 72 °C for 60 s, and                          
terminal extension at 72 °C for 7 min with fusion polymerase (NEB). The resulting PCR               
product of 1,869 bp in length was sequenced from both sides with the primers used in the                 
PCR amplification. 
Construction of virus reporter vectors and virus propagation 
The original virus bearing PR-RSV-C was expressed from plasmid pPrC, which was            
obtained from K. Beemon, Johns Hopkins University, Baltimore ​(Ogert, Lee, and Beemon            
1996) and amplified in DF-1 cells with a resulting titer ∼10​5 FFU. The viral particles were                
concentrated by ultracentrifugation through 25% sucrose cushion at 32,000 rpm for 2 h in a               
Beckman SW38 rotor. RCAS(C)GFP and RCAS(H20)GFP were prepared by env          
replacement from retroviral vector RCASBP(C)GFP ​(M. J. Federspiel and Hughes 1997)           
transducing the green fluorescent protein (GFP) reporter gene. env from H20 cells and from              
pPrC was amplified using the forward primer PolEnd_fw and reverse primer EnvEnd_StuI_rv            
by fusion polymerase with the same conditions as mentioned above. PCR products were             
adenylated and cloned in pGEM-T Easy plasmid vector (Promega). The resulting           
pGEM-EnvC and pGEM-EnvH20 as well as vector RCASBP(C)GFP were digested with KpnI            
and StuI restriction enzymes and the 1,853-bp fragment containing the 3′ end of pol and the                
entire env gene from RCASBP(C)GFP was replaced with equal-length fragments from           
pGEM-EnvC or pGEM-EnvH20. Chimeric constructs EnvC-H20Parts1–4 were prepared by         
replacement of one specific part of EnvC by EnvH20. pGEM-EnvC and pGEM-EnvH20 were             
digested with NheI and AgeI for EnvH20Part1, AgeI and HindIII for EnvH20Part2, HindIII and              
Xma for EnvH20Part3, and Xma and StuI for EnvH20Part4. The cleaved fragment from             
pGEM-EnvC was replaced with the equal-length fragment from pGEM-EnvH20. The          
resulting chimeric pGEM-EnvC-H20Parts1–4 was digested with KpnI and StuI and inserted           
into cleaved RCASBP(C)GFP in the same way as described for RCAS(C)GFP.           
EnvC-L378S, EnvC-G464S, and EnvC-L503V are constructed harboring EnvC with one          
specific mutation and were prepared by PCR mutagenesis and In-Fusion cloning. Fifty            
nanograms of pGEM-EnvC were amplified with primers bearing mutation, primers          
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5′-CGCAAGCCTCAAGAGAAATTGAGAGAC and 5′-TTCTCTTGAGGCTTGCGCAGCT for    
EnvC-L378S, 5′-TAAGATCAGCGTGGACAGCGACC and   
5′-GTCCACGCTGATCTTATTGACATGTTTC for EnvC-G464S, and    
5′-ATTGCTAGTGGTGTGCCTGCCTT and  
GGCACACCACTAGCAATAAAATAACTACAAGCC for EnvC-L503V. The following PCR      
conditions were used: 98 °C for 30 s, 36 cycles of 98 °C for 15 s, 70 °C for 30 s, and 72 °C                        
for 3 min, and terminal extension at 72 °C for 7 min with fusion polymerase (NEB). The                 
resulting PCR product (4,900 bp) was cleaved with DpnI to get rid of the original               
pGEM-EnvC and recircularized by In-Fusion HD Cloning Kit (Clontech) according to the            
manufacturer’s protocol. pGEM-EnvC with the particular mutation was digested with KpnI           
and StuI and inserted into cleaved RCASBP(C)GFP in the same way as described for              
RCAS(C)GFP. EnvB-H20Part4 was prepared from RCASBP(B)GFP ​(M. J. Federspiel and          
Hughes 1997)​. Part of the env gene encoding the surface subunit of EnvB was amplified               
with primers 5′-TCGATTTTTGGGTACCCTCTCGGA and 5′-CTTGTGCAGCTGCTACCC     
from template RCASBP(B)GFP with fusion polymerase. The resulting PCR product was           
inserted into pGEM-EnvC-H20Part4, which was cleaved with KpnI–XmaI using In-Fusion HD           
Cloning Kit. The resulting vector pGEM-EnvB-H20Part4 as well as vector RCAS(C)GFP           
were cleaved with KpnI and BstBI, and the 1,797-bp fragment from RCAS(C)GFP was             
discarded and replaced with same-length fragments from pGEM-EnvB-H20Part4. All viruses          
were propagated in the same way. DF-1 cells were transfected with viral constructs using              
Lipofectamine 3000 (Thermo Fisher Scientific) according to the producer’s protocol and the            
viruses were amplified for 2–3 weeks. The medium was then collected, centrifuged (3,850 ×              
g, 20 min, 4 °C), and filtered through a 0.45-µm filter. Aliquots were stored at −80 °C. 
Quantification of proviral DNA in infected cells 
NIL-2 and NIL-Tvc cells were seeded at a density of 5 × 10​3 per well in a 96-well plate. Five                    
hours after seeding, the cells were pretreated for 30 min with 50 µL of medium with                
polybrene (20 µg/mL) and infected with 50 µL of medium containing virus. Before infection,              
all viral stocks were treated with DNase for 30 min at 37 °C to get rid of residual viral DNA.                    
On days 1, 3, 6, and 9 after infection, the cells were washed with PBS and resuspended in                  
100 µL of lysis buffer (10 mM Tris⋅HCl pH 8.0, 1 mM EDTA, 0.2 mM CaCl2, 0.001% Triton                  
X-100, 0.001% SDS, 1 mg/mL proteinase K). The resuspended cells were incubated at 58              
°C for 1 h and then the protease was heat-inactivated at 95 °C for 10 min. Aliquots (4 μL)                   
were analyzed by real-time quantitative PCR based on the MESA GREEN qPCR MasterMix             
Plus for SYBR Assay Kit (Eurogentec) and a CFX96 system for qPCR detection (Bio-Rad).              
Quantifications of viral transcripts were performed with primers        
5′-GCCAGGGAACCTTTGGATTA and 5′-CCCTTAAAATCACCTTCGGAAA in env gene or       
5′-ACGTAAACGGCCACAAGTTC and 5′- TGCAGATGAACTTCAGGGTCAG in gfp. Results       
were normalized to the amount of mGAPDH genomic locus, which was measured with             
primers 5′-AACTTTGGCATTGTGGAAGG and 5′-ATCCACAGTCTTCTGGGTGG. The     
volume of the reaction mixture was 20 μL with 400 nM final concentration of each primer.                
Cycling conditions were 95 °C for 5 min, 40 cycles of 95 °C for 15 s, 61 °C for 20 s, and 72                       
°C for 20 s. Calibration curves were prepared by amplification of diluted plasmid samples              
ranging from 10​2​ to 10​7​ copies per reaction. 
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Determination of viral titers 
PR-RSV-C and H20-RSV viruses were titrated by the infectious center assay described            
previously ​(Svoboda and Dourmashkin 1969)​. RCAS-EnvC-GFP, RCAS-EnvH20-GFP, and        
all other env-mutant viruses derived from these two vectors were titrated using flow             
cytometry. DF-1 and HEK293 cells were seeded at a density of 5 × 10​4 per well in a 24-well                   
plate; NIL-2, NIL-Tvc, and RPE1-hTERT were seeded at a density of 2.5 × 10​4 per well in a                  
24-well plate. Five hours after seeding, the cells were pretreated for 30 min with 200 µL of                 
medium with polybrene (20 µg/mL) and infected with 200 µL of the virus-containing medium.              
The next day, the medium was replaced and in the case of DF-1 cells, AZT (final                
concentration 5 µM) was added into the new media 24 h postinfection. The percentage of               
GFP+ cells was quantified by fluorescence-activated cells sorting (FACS) using an LSRII            
analyzer (Becton, Dickinson) 2 d (in the case of DF-1 and HEK293 cells) or 3 d (in the case                   
of NIL-2, NIL-Tvc, and RPE1 cells) postinfection. The cells were trypsinized and washed with              
PBS before the analysis. The viral titer was determined from the following formula: TU/mL =               
(1/dilution) × (1/volume used to infect) × (cells per well at the time of infection) × [−ln (1 −                   
positive fraction)] ​(Rainey et al. 2003)​. 
Virus purification 
Viruses used for the pH inactivation assay, PMB inhibition, and TM oligomerization assays             
were concentrated from culture supernatants by ultracentrifugation through a 25% sucrose           
cushion in HN buffer [10 mM Hepes, 130 mM NaCl (pH 8.0)], and then resuspended in a                 
small volume of HN buffer overnight at 4 °C. 
Temperature-sensitivity assay of virions 
Virus stocks in the culture medium were diluted to a similar titer and aliquoted into five                
samples, which were incubated for 0, 2, 4, 6, or 8 h at 44 °C and transferred to ice. DF-1                    
cells and NIL-Tvc cells were infected as described above. The next day, DF-1 cells were               
harvested for quantification of newly made viral DNA. NIL-Tvc cells were analyzed for GFP              
expression by flow cytometry 3 d after infection. 
pH inactivation assay 
Virus inactivation by low pH was performed as described previously ​(Mitsialis et al. 1983)​. To               
modify the pH, virions in the HN buffer were diluted 100-fold in a medium that was kept at pH                   
7.4 or adjusted to pH 5.0 with HCl. The samples were then incubated either on ice or at 37                   
°C for 30 min before neutralization with an equal volume of medium buffered with 25 mM                
Hepes (pH 7.4). The virus was then added to DF-1 cells in 24-well plates, and the next day                  
the medium was replaced and AZT (final concentration 5 µM) was added. Two days after               




PMB inhibition of virus infection was performed as described previously ​(Walther Mothes et             
al. 2000)​. PMB (Thermo Fisher Scientific) was dissolved in the HN buffer and added into the                
virus preparation in the HN buffer to the indicated final concentrations. Samples were             
incubated at 37 °C for 30 min, cooled on ice, diluted in growth medium supplemented with                
40 mM Hepes, and added on ice to 24-well plates of DF-1 cells that were washed with                 
chilled PBS. Plates were centrifuged for 2.5 h at 1,520 × g, 4 °C. The medium was changed                  
on ice and plates were then transferred to a 37 °C incubator. The next day, the medium was                  
changed and AZT (final concentration 5 µM) was added. Two days after infection, GFP              
expression was analyzed by flow cytometry. 
Production of liposomes 
Liposomes were produced by a modification of the protocol described previously ​(Earp et al.              
2003)​. Liposomes were always freshly prepared before each experiment as a 2:1 molar ratio              
mixture of egg phospholipids and cholesterol (Sigma) in chloroform. Hen egg phospholipids            
were isolated according to method 2 by Gladkowski et al. ​(Gładkowski et al. 2012)​. The               
concentration of phospholipids was determined by molybdenum blue reaction ​(Rouser,          
Fkeischer, and Yamamoto 1970)​. The lipid mixture was dried down to a thin film in a                
round-bottom glass tube under a constant stream of nitrogen at room temperature. After             
resuspension in PBS by extensive vortexing, liposomes were sonicated twice for 60 s at 43               
°C in a water bath sonicator and then extruded 25 times through a 0.1-μm pore size                
polycarbonate membrane (Avestin) in a LiposoFast Basic apparatus (Avestin). 
Product-enhanced reverse transcriptase assay 
The product-enhanced reverse transcriptase (PERT) assay was performed as described          
previously ​(Fábryová et al. 2015)​. In each run, one positive control (ASLV of defined titer)               
and one negative control (culture medium of uninfected cells) were included. 
Inoculation of chicken embryos 
Outbred Brown Leghorn chickens were used ​(Plachý and Hála 1997)​. On day 12 of              
embryonal development, we have injected 0,1 ml of virus stocks into the chorioallantoic vein.              
The animals were sacrificed and examined when signs of suffering were spotted or when the               
experiment was ended. Upon sacrifice, chickens were examined for bone transformation. 
For time dependent experiments, we inoculated embryos on days 10, 13, or 17 or at day 0 or                  
7 post-hatching. For the dose-dependent experiment, we have used only embryos at day 12              
for inoculation of diluted viruses. 
All procedures were performed in accordance with the ​Guide for the Care and Use of               
Laboratory Animals ​(National Research Council (U.S.). Institute of Laboratory Animal          
Resources (U.S.). Committee on Care and Use of Laboratory Animals 1985) and approved             
by the Animal Care and Use Committee of the Academy of Sciences of the Czech Republic. 
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Virus sequencing and comparative analysis 
Genomic DNA of osteopetrotic bones was obtained by freezing the samples in liquid             
nitrogen, pulverized, mixed with DNA lysis solution (1% SDS, 250 mmol/L EDTA, and 1              
mg/mL proteinase K) and incubated 50°C o/n. The solution was extracted by            
phenol-chloroform (1:1), DNA containing phase was mixed with 96% EtOH, spun, washed by             
80% EtOH and resuspended in TE buffer (10 mmol/L Tris-Cl (pH 8.3) and 1 mmol/L EDTA).                
Extracted DNA served as a template for PCR under following conditions: AccuTaq            
polymerase (Sigma) with AccuTaq buffer supplemented with 500 μmol/l of deoxynucleotide           
triphosphates was mixed with forward (5′-TGTAGTCTTAATCATAGGTTAACATGTA​-3'​) and       
reverse primer (5′-CAGAATACTCCCTCTAACCATAGCCACTGCG​-3'​) for amplification of      
LTR-gag region, forward (5′-ATCCATGGGATAGGAGGGGGAATT​-3'​) and reverse primer       
(5′-TGCTGGTCTGGGGACGAGGTTATGC​-3'​) for amplification of pol region and forward        
(5′-CTATTAGCCAAGGCAGTGTATGCCCTTAAT​-3'​) and reverse   
(5′-CAAATAAGGGAATCGCCTGATGCACC) primers for amplification of env-LTR region.       
Fragments were purified by EtOH standard protocol. Samples were sequenced using           
Sanger sequencing protocol by Seqme with following primers:        
(5′-TGTAGTCTTAATCATAGGTTAACATGTA​-3'​), (5′-ACTCCCCGGGGTCCTGGGATC​-3'​)  
and (5′-TAACTTGGATCGCTTAAAGGGTCTAG​-3'​) for sequencing of LTR-gag fragment,       
(5′-ATCCATGGGATAGGAGGGGGAATT), (5′-GTACGTATGTAGCACCCGTAGG​-3'​) and   
(5′-TGCTGTGGCCGACAACGCCC​-3'​) for sequencing pol region and      
(5′-CTATTAGCCAAGGCAGTGTATGCCCTTAAT​-3'​), 
(5′-ACTCACCGGTTAGTCTCGAGAGGT​-3'​) and  
5′-(AGCTTACCATGTTAGCACCCAACC​-3'​) for sequencing of env-LTR region.  
Obtained sequences were compared to MQNCSU (GenBank accession no. DQ365814.1),          
LR-9 (GenBank accession no. AY350569.1), Pr-C (GenBank accession no. V01197.1), RSA           
(GenBank accession no. M37980.1), MAV-2 (GenBank accession no. L10924.1), and          
MAV-2.O and MAV-1/2.O as presented by ​(Joliot et al. 1993)​. 
MAV-2.O substitutions-derived vectors 
Selected substitutions were introduced into MCAS(B) GFP vector employing the Phusion           
PCR two-step protocol (NEB) with the following PCR conditions for all reaction: 98 °C for 30                
s, 35 cycles of 98 °C for 15 s, 60 °C for 30 s, and 65 °C for 2 min, and terminal extension at                        
72 °C for 5 min. For LTR-derived 160, 194, and 372, we have used forward               
(​5′-​TTTATTACCAAGCGAAGCGCCATTC​-3′​) and reverse primers    
(​5′-​CCCAGGACCCCGGGGAGTATAAG​-3′) to flank the LTR target area for PCR-driven         
mutagenesis and forward (5′-CCTTCCTCATCAGATCATGTACGCGGCAGAG-3′) and     
reverse (5′-CTCTGCCGCGTACATGATCTGATGAGGAAGG-3′) primers for introducing 160      
substitution, forward (5′-ATGATTGGATAACTGGATGGCACCATTCAT-3′) and reverse     
(5′-ATGAATGGTGCCATCCAGTTATCCAATCAT-3′) primers for introducing 194 substitution      
and forward (5′-ACGACTACGAGCACCTGCATGAAGCA-3′) and reverse     
(5′-TGCTTCATGCAGGTGCTCGTAGTCGT-3′) primers for introducing 372 substitution. We       
have used pMAV-left plasmid as a template for this reaction. 
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For pol-derived ​A683V and M765V substitutions, we have used forward          
(​5′-​GCACCACTGCTGCCTTGGAGCG​-3′​) and reverse   
(​5′-​TGTTGTGTGGAATTGTGAGCGGA​-3′​) primers to flank the pol target area for         
PCR-driven mutagenesis and forward (​5′-​CTACGGCTATCGCCGTTTTGGGAAGACC​-3′​)     
and reverse (​5′-​GGTCTTCCCAAAACGGCGATAGCCGTAG​-3′​) primers for introducing      
A683V substitution and forward (​5′-​CTATTAGCCAAGGCAGTGTATGCCCTCAAT​-3′​) and      
reverse (​5′-​ATTGAGGGCATACACTGCCTTGGCTAATAG​-3′​) primers for introducing M765V      
substitution.​ We have used pMAV-left plasmid as a template for this reaction. 
For env-derived ​A28T, (also pol-derived S880N) L387S and A398T substitutions, we have            
used forward (​5′-​TGGCAGTAATTTGGGTAATGTC​-3′​) and reverse     
(​5′-​TGTCTTTCCTGCCTTGCTCGATGG​-3′​) primers to flank the TM target area and forward          
(​5′-​TTTATTACCAAGCGAAGCGCCATTC​-3′​) and reverse   
(​5′-​CCCTGGGTCGGTCGAAAGGATGTG​-3′​) primers to flank the signal peptide target area         
and forward (​5′-​GCTGCGCAAGCCTCAAGAGAAATCGAG​-3′​) and reverse     
(​5′-​CTCGATTTCTCTTGAGGCTTGCGCAGC​-3′​) primers for introducing ​L387S substitution,      
forward (​5′-​GGTCCGTTAAACAGACTAATTTGACAACATC​-3′​) and reverse    
(​5′-​GATGTTGTCAAATTAGTCTGTTTAACGGACC​-3′​) primers for ​introducing ​A398T     
substitution and forward (​5′-​GAAGAAACCGCCAGCAACAAGCAAGAAAGA​-3′​) and reverse      
(​5′-​TCTTTCTTGCTTGTTGCTGGCGGTTTCTTC​-3′​) primers for introducing ​A28T     
substitution. ​ We have used pMCAS-right GFP plasmid as a template for this reaction. 
All amplified sequences were purified by LMP agarose gel, excised, and isolated by the              
standard phenol extraction protocol ​(“Current Protocols in Molecular Biology” 1993) and           
mixed for the next step of PCR amplification according to ​Phusion PCR two-step protocol              
(NEB) with following PCR conditions for all reaction: 98 °C for 30 s, 15 cycles of 98 °C for                   
15 s, 60 °C for 30 s, and 65 °C for 3 min, and terminal extension at 72 °C for 5 min. All                       
samples were purified by standard ethanol precipitation protocol ​(“Current Protocols in           
Molecular Biology” 1993) and digested as follows: LTR-derived substitutions fragments,          
together with ​pMAV-left plasmid were digested by PvuII-Sal, pol-derived substitutions          
fragments together with pMAV-left plasmid were digested by PmlI-KpnI, TM-derived          
substitutions fragments together with pMCAS-right GFP plasmid were digested by          
SmaI-SacI and leader peptide-derived substitutions fragments together with pMCAS-right         
GFP plasmid were digested by PvuII-BamHI and purified by LMP agarose gel as described              
above. Fragments were ligated with respective digested plasmids following T4 ligase           
protocol (NEB). For the generation of vectors with multiple MAV-2.O-derived genes, multiple            
steps of Phusion PCR or digestion, as described above, were taken. To produce the final               
vector for virus production, pMAV-left and pMCAS-right GFP were digested by KpnI-BsiWI,            
purified by LMP agarose gel, and env-LTR fragment of pMCAS-right GFP was ligated into              
pMAV-left backbone. 
Introduction of MAV-2.O env-derived substitutions into A, C and         
K subgroups 
For the production of A subgroup-derived vector, we have digested plasmids pAT-MAV-1            
(plasmid with pAT153 backbone containing MAV-1 (GenBank accession no. L10922.1) and           
pMAV-left by KpnI-SacI, purified by LMP agarose gel protocol described above and ligated             
by T4 ligase. For the production of C and K subgroups-derived vectors, we have employed               
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Phusion PCR protocol using forward (5′-AGTCAGCCACCTCCCCTTTT-3′) and reverse        
(5′-TGCCT​GAGCTC​TAGACTGCTCCGCCCTGCAT​-3′) primers for subgroup C (template      
pPrC) and forward (5′-AGTCAGCCACCTCCCCTTTT-3′) and reverse      
(5′-TGCCT​GAGCTC​TAGACCGCCCCATTTTCAGGCTG-3′) primers for subgroup K     
(template pRCAS(JS11C1)GFP to introduce SacI restriction site (site underlined) at the end            
of env gene under following PCR conditions: ​98 °C for 30 s, 35 cycles of 98 °C for 15 s, 60                     
°C for 30 s, and 65 °C for 2 min, and terminal extension at 72 °C for 5 min. Amplified                    
sequences were purified by EtOH standard protocol and digested by SmaI-SacI. Next, we             
have digested pMCAS-B-right GFP plasmid by KpnI-SacI and ​pPrC and          
RCAS(JS11C1)GFP by KpnI-SmaI and purified them by LMP agarose gel. We have mixed             
digested fragments obtained from Phusion PCR reaction with digested pMCAS(B)-right-GFP          
and pPrC for production of pMCAS(C)GFP-right or RCAS(JS11C1)GFP for production of           
pMCAS(K)-right GFP together with T4 ligase. To introduce MAV-2.O env-derived          
substitutions, we have employed the Phusion PCR two-step protocol (NEB) with the            
following PCR conditions for all reaction: 98 °C for 30 s, 35 cycles of 98 °C for 15 s, 60 °C                     
for 30 s, and 65 °C for 2 min, and terminal extension at 72 °C for 5 min with forward                    
(5′-AGTCAGCCACCTCCCCTTTT-3′) and reverse   
(​5′-​TGTCTTTCCTGCCTTGCTCGATGG​-3′​) primers to flank the TM target area and forward          
(​5′-​GCTGCGCAAGCCTCAAGAGAAATTGAG​-3′​) and reverse   
(​5′-​CTCAATTTCTCTTGAGGCTTGCGCAGC​-3′​) primers to introduce ​L387S substitution into       
A and C-derived vectors (as template served MCAS(A)-right GFP and pMCAS(C)-right GFP,            
respectively) and forward (​5′-​GCTGCGCAAGCCTCAAGAGAAATCGAG​-3′​) and reverse      
(​5′-​CTCGATTTCTCTTGAGGCTTGCGCAGC​-3′​) primers for introducing ​L387S substitution      
into K-derived vector (as template served pMCAS(K)-right GFP). To introduce A398T           
substitution, we have used forward (​5′-​GGTCCGTTAAACAGACTAACTTGACAACATC​-3′​)      
and reverse (​5′-​GATGTTGTCAAGTTAGTCTGTTTAACGGACC​-3′​) primers for A, C, and        
K-derived vectors, with respective templates. All respective fragments were mixed and           
underwent the second step of two-step Phison PCR reaction under the following conditions:             
98 °C for 30 s, 15 cycles of 98 °C for 15 s, 60 °C for 30 s, and 65 °C for 3 min, and terminal                          
extension at 72 °C for 5 min. All obtained fragments were purified by standard EtOH               
protocol, digested by SmaI-SacI together with respective vectors, purified by LMP agarose            
gel, and ligated by T4 ligase. To introduce multiple substitutions, multiple steps were             
repeated with different primers. 
Construction of pMCAS vector with multiple cloning site and         
P2A self-cleaving peptide 
To construct MCAS based vector with neomycin resistance gene, we have introduced            
multiple cloning site (containing ClaI, MreI, NotI, AsiSI, SpeI, AscI, PmeI and SgrI unique              
restriction sites) using forward    
(5'-ATCGATCGCCGGCGGCCGCGATCGCACTAGTGGCGCGCCGTTTAAACGTCGACGA
T-3') and reverse   
(5'-TAGCAGCTGCAAATTTGCCGCGCGGTGATCACGCTAGCGCCGGCGGCCGCTAGCT
A-3') oligomers, which were hybridised digested by ClaI together with pMCAS(B)-right GFP            
and ligated by T4 ligase, creating pMCASCS(B)-right GFP To add P2A self-cleaving peptide,             
we have employed Phusion PCR protocol using pMCASCS(B)-right GFP as template and            
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forward (​5′-​TCTGTGTTCTGCAGGGCAGCATGGTGAGCAAGGGCGA-3') and reverse    
(​5′-​GGCCGCCGGCGATCGATGGGTCCCGGATTCTCTTCCACATCTCCAGCCTGCTTGAG
CAATGAAAAATTGGTTGCTCCTGACCCCTTGTACAGCTCGTCCATGCCGA-3') primers  
under following conditions: 98 °C for 30 s, 3 cycles of 98 °C for 15 s, 65 °C for 30 s, and 68                       
°C for 4 min, 25 cycles of 98 °C for 15 s, 65 °C for 30 s, and 72 °C for 4 min, and terminal                         
extension at 72 °C for 10 min. The amplified fragment was introduced into             
pMCASCS(B)-right GFP digested by BamHI using In-Fusion HD cloning kit (Clontech),           
producing pMCASII(B)-right GFP. For introducing neo gene, we have employed Phusion           
PCR protocol using forward (​5′-​CCC​ATCGAT​CAAGATGGATTGCACGCAGGTTCT-3') and      
reverse (​5′-​A​GCGGCC​GCTCAGAAGAACTCGTCAAGAAGGCG-3') primers, introducing    
ClaI and NotI restriction sites (underlined) into the amplified fragment. We used pcDNA3             
plasmid (Invitrogen) as a template and PCR was performed under the following conditions:             
98 °C for 30 s, 35 cycles of 98 °C for 15 s, 60 °C for 30 s, and 65 °C for 2 min, and terminal                          
extension at 72 °C for 5 min. We have purified amplified fragments by standard EtOH               
protocol and digested them together with pMCAS(B)II-right-GFP vector using ClaI-NotI. Both           
were purified by LMP agarose gel procedure and ligated by T4 ligase. Vector then served as                
a template for site-directed mutagenesis as described above. 
Comparative analysis of MAV-2.O and selected ALV strains 
Genomic DNA of osteopetrotic bones was obtained by freezing the samples in liquid             
nitrogen, dusting, mixed with DNA lysis solution (1% SDS, 250 mmol/L EDTA, and 1 mg/mL               
proteinase K) and incubated 50°C o/n. Solution was extracted by phenol-chloroform (1:1),            
DNA containing phase was mixed with 96% EtOH, spun, washed by 80% EtOH, and              
resuspended in TE buffer (10 mmol/L Tris-Cl (pH 8.3) and 1 mmol/L EDTA). Extracted DNA               
served as a template for PCR under following conditions: AccuTaq polymerase (Sigma) with             
AccuTaq buffer supplemented with 500 μmol/l of deoxynucleotide triphosphates was mixed           
with forward (5′-TGTAGTCTTAATCATAGGTTAACATGTA​-3'​) and reverse primer      
(5′-CAGAATACTCCCTCTAACCATAGCCACTGCG​-3'​) for amplification of LTR-gag region,      
forward (5′-ATCCATGGGATAGGAGGGGGAATT​-3'​) and reverse primer     
(5′-TGCTGGTCTGGGGACGAGGTTATGC​-3'​) for amplification of pol region and forward        
(5′-CTATTAGCCAAGGCAGTGTATGCCCTTAAT​-3'​) and reverse   
(5′-CAAATAAGGGAATCGCCTGATGCACC) primers for amplification of env-LTR region.       
Fragments were purified by EtOH standard protocol. Samples were sequenced using           
Sanger sequencing protocol by Seqme with following primers:        
(5′-TGTAGTCTTAATCATAGGTTAACATGTA​-3'​), (5′-ACTCCCCGGGGTCCTGGGATC​-3'​)  
and (5′-TAACTTGGATCGCTTAAAGGGTCTAG​-3'​) for sequencing of LTR-gag fragment,       
(5′-ATCCATGGGATAGGAGGGGGAATT), (5′-GTACGTATGTAGCACCCGTAGG​-3'​) and   
(5′-TGCTGTGGCCGACAACGCCC​-3'​) for sequencing pol region and      
(5′-CTATTAGCCAAGGCAGTGTATGCCCTTAAT​-3'​), 
(5′-ACTCACCGGTTAGTCTCGAGAGGT​-3'​) and  
5′-(AGCTTACCATGTTAGCACCCAACC​-3'​) for sequencing of env-LTR region. Obtained       
sequences were compared to MQNCSU (GenBank accession no. DQ365814.1), LR-9          
(GenBank accession no. AY350569.1), Pr-C (GenBank accession no. V01197.1), RSA          
(GenBank accession no. M37980.1), MAV-2 (GenBank accession no. L10924.1), and          
MAV-2.O and MAV-1/2.O as presented by ​(Joliot et al. 1993)​. 
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Infection of cells with MAV-2.O-derived substitutions vectors 
Cells were analysed using flow cytometry. Cells were seeded at a density of 5 × 10​4 per well                  
in a 24-well plate. Eight hours after seeding, the cells were infected with 100 µl (original                
protocol) or with 1 ml (adjusted protocol) of the virus-containing medium. Cells were             
harvested by PBS wash and trypsinization two days later The percentage of GFP+ cells was               
quantified by fluorescence-activated cells sorting (FACS) using an LSRII analyzer (Becton,           
Dickinson). 
Temperature-Sensitivity Assay of vectors 
Virus stocks in the culture medium were aliquoted into three samples, which were incubated              
for 0, 12, or 24 hours at 44 °C and transferred to ice. DF-1 cells were infected as described                   
above. three days later, DF-1 cells were harvested and analyzed for GFP expression by flow               











ALV-K subgroup definition and Tvk identification 
RCAS(JS11C1)GFP host range 
To investigate the host range of postulated subgroup K ​(Wang X., Zhao, and Cui 2012)​, we                
cloned JS11C1 ALV strain env into an ALV-based RCAS vector encoding green fluorescent             
protein (GFP). Env was synthesized according to the published sequence (GenBank           
accession no. KF746200) and replaced the env gene of RCAS(D)GFP, resulting in            
RCAS(JS11C1)GFP. Virus titer of 10 ​̂6 infectious units (UI) per ml was produced by             
transfection of DF-1 cells. Replication competence of the resulting virus was confirmed by             
the virus spread in DF-1 cells and increased percentage of GFP-positive cells. 
In order to delineate the host range of JS11C1, we cultured and infected embryo fibroblasts               
of multiple galliform birds to test them for susceptibility or resistance to the JS11C1. Our               
panel contained species susceptible or resistant to subgroups A-E and J which enables             
comparison of the host ranges. We infected cells with RCAS(A)GFP in parallel as a control.               
As expected, cells were infected with different efficiency by both viruses, with highest rates              
in the case of QT6 cells derived from Japanese quail, then gradually lowering for both               
viruses. Three species of New World quails, ring-neck pheasant and gray partridge,            
displayed the lowest positivity for virus infection in the case of RCAS(JS11C1)GFP and             
lowest to none positivity in the case of RCAS(A)GFP. As previously described, New World              
quails bear a W48S substitution in the Tva receptor, probably disrupting the subgroup A              
virus binding site, thus rendering quails resistant. A similar effect was observed in the case               
of red jungle fowl, as cells were susceptible to RCAS(JS11C1)GFP infection while nearly             
resistant to RCAS(A)GFP. The resistance of red jungle fowl was explained previously by             
intronic deletion of the branch point signal in the Tva receptor lowering the expression of the                
protein ​(Reinišová et al. 2012)​. Guinea fowl exhibited a reverse pattern, as derived cells              
were highly positive for infection of RCAS(A)GFP, but completely resistant to           
RCAS(JS11C1)GFP. Embryo fibroblasts derived from the domestic duck were resistant to           
both viruses. 
We also investigated embryo fibroblasts derived from inbred lines, as their receptors for ALV              
viruses had been already characterized. We observed infection in lines WA, L15 and H6,              
though RCAS(JS11C1)GFP infected 2-10× more cells than RCAS(A)GFP. In case of M and             
CB lines, we observed low to none infection by RCAS(JS11C1)GFP and nearly complete             
resistance to infection by RCAS(A)GFP. These findings were in accordance with the intronic             
deletion found in red jungle fowl and C40W substitution, as described previously. 
In summary, the host range of RCAS(JS11C1)GFP differs from that of other subgroups, as              
compared to RCAS(A)GFP in our experiment or to other subgroups from previous studies.             
At the same time, we observed similarities in the host range of the viruses analyzed in our                 
study and similar reaction to the Tva depletion or structure changes, suggesting that             





Figure A1.: ​Alignment of the amino acid sequences of ALV subgroup A and subgroup              
K envelope glycoproteins 
Amino acid sequences deduced from the available GenBank data are shown. Subgroup A is              
represented by the Schmidt-Ruppin A (SR-A) strain (GenBank accession no. NP040548),           
and subgroup K is represented by the Chinese and Taiwanese nonrecombinant strains            
JS11C1 (GenBank accession no. ​KF746200​), JS13LY19 (GenBank accession no.         
AWO14321​), GD14LZ (GenBank accession no. ​ANW72067​), TW-3593 (GenBank accession         
no. ​ADP21276​), Km_5845 (GenBank accession no. ​BAL70358​), and GDFX0601 (GenBank          
accession no. ​AKP18446​). Identical amino acids are highlighted in black. Gaps are indicated             
by dots. The main functional domains of envelope glycoproteins are delineated above the             
sequence. SU, surface subunit; TM, transmembrane subunit; vr1, vr2, and vr3, variable            
regions 1 to 3; hr1 and hr2, hypervariable regions 1 and 2; HR1 and HR2, heptad repeats 1                  





Figure A2.: Host range of     
RCASBP(JS11C1)GFP in galliform   
species and inbred lines of domestic      
chickens 
(A) Time courses of RCASBP(JS11C1)GFP     
and RCASBP(A)GFP infection in DF-1     
cells. The percentages of GFP-positive     
cells in the three consecutive days after       
infection are shown as means and standard       
deviations of triplicate assays. (B)     
Efficiency of RCASBP(JS11C1)GFP and    
RCASBP(A)GFP infection, measured as    
the percentages of GFP-positive cells three      
days after infection for cultured embryo      
fibroblasts of 14 galliform species (Reeve’s      
pheasant [SR], turkey [MG], silver pheasant      
[LN], white-crested kalij pheasant [LL], gray      
jungle fowl [GS], Mrs. Hume’s pheasant      
[SH], chukar [AC], northern bobwhite [CV],      
California quail [CC], Gambel’s quail [CG],      
gray partridge [PP], ringed-neck pheasant     
[PC], red jungle fowl [GG], and guinea fowl        
[NM]), QT6 cells representing the Japanese      
quail (JQ), and embryo fibroblasts of the       
domestic duck (AP). Results are shown as       
means ± standard deviations of duplicate      
assays. (C) Efficiency of    
RCASBP(JS11C1)GFP and  
RCASBP(A)GFP infection in cultured    
embryo fibroblasts of five inbred chicken      






RCAS(JS11C1)GFP interferes with the A subgroup 
We substituted GFP for red fluorescent marker dsRed in our RCAS vectors creating             
RCAS(A)dsRed and RCAS(JS11C1)dsRed. Vectors encoding different fluorescent dyes        
enable examination of infection of cells pre-infected with different viruses using FACS to             
analyze GFP-positive, dsRed-positive, and GFP/dsRed-double-positive cells. 
We pre-infected DF-1 cells with RCAS(A)GFP, RCAS(B)GFP, and RCAS(J)GFP in parallel           
and superinfected the cells with RCAS(A)dsRed or RCAS(JS11C1)dsRed after one week.           
Preinfection of the cells resulted in about 85% GFP-positive cells for subgroup A, about              
100% for subgroup B and about 50% for subgroup J. The inability of RCAS(A)GFP and               
RCAS(J)GFP to infect all cells may be due to the fact that GFP-defective virus emerged               
during the infection using low multiplicity of infection (MOI). Superinfection by subgroups A             
and K resulted in the absence of dsRed- or double-positive cells pre-infected by subgroup A,               
roughly 100% of double-positive cells pre-infected by subgroup B and 50% of dsRed-positive             
and 50% of double-positive cells pre-infected by subgroup J. 
As superinfection of subgroups A and K gave the same result, strong interference with              
subgroup A preinfection, we suggest that they belong to the same interference group,             
sharing the same receptor. 
Tva is sufficient for RCAS(JS11C1)GFP infection 
As we observed a similar host range and interference of RCAS(A)GFP and            
RCAS(JS11C1)GFP, we tested whether expression of ectopic Tva in cells of resistant            
species is sufficient for RCAS(JS11C1)GFP infection. 
We stably transfected NIL-2 cells of Syrian hamster (species resistant to all ALV subgroups)              
with chicken Tva or Tvc in parallel as a control. NIL-Tva and NIL-Tvc clones, together with                
the control chicken DF-1 cell line, were infected with RCAS(A)GFP, RCAS(JS11C1)GFP,           
RCAS(B)GFP and RCAS(C)GFP. DF-1 cells were infected with similar efficiency by all            
viruses (77-95% of GFP-positive cells). NIL-Tva cells were susceptible to RCAS(A)GFP and            
RCAS(JS11C1)GFP but resistant to RCAS(B)GFP and RCAS(C)GFP. Finally, NIL-Tvc cells          
were susceptible only to RCAS(C)GFP and resistance to the rest of the viruses. 
As an expression of Tva rendered resistant NIL-2 cells susceptible, we conclude that Tva is               








Figure A3.:​ ​Superinfection interference between ALV-A and ALV-K subgroups 
(A) Results of interference experiments shown as FACS dot plots. Preinfection of DF-1 cells              
with RCASBP(A)GFP blocks superinfection with RCASBP(JS11C1)dsRed (left), whereas        
preinfection with RCASBP(B)GFP (middle) or RCASBP(J)GFP (right) permits subsequent         
superinfection with RCASBP(JS11C1)dsRed. Horizontal axes, dsRed positivity; vertical        
axes, GFP positivity. (B) The efficiency of superinfection interference between          
RCASBP(A)GFP, RCASBP(B)GFP, and RCASBP(J)GFP as preinfection viruses and        
RCASBP(A)dsRed and RCASBP(JS11C1)dsRed as superinfection viruses. The results are         
shown as mean percentages of GFP-negative/dsRed-negative,      
GFP-positive/dsRed-negative, GFP-negative/dsRed-positive, and   




Tva is required for RCAS(JS11C1)GFP infection 
Having demonstrated that the ALV-A receptor, Tva, is sufficient for RCAS(JS11C1)GFP           
infection, we tested the effect of its depletion in chicken cells. 
We employed the clustered regularly interspaced short palindromic repeat         
(CRISPR)/CRISPR-associated protein 9 (Cas9) system to prepare chicken DF-1 cells          
bearing homozygous frameshift deletion within the ​tva gene, resulting in the DF-1-tva-/- cell             
clone. We infected this clone with RCAS(A)GFP, RCAS(JS11C1)GFP, RCAS(B)GFP and          
RCAS(C)GFP. While we observed a high level of GFP-positive cells of the DF-1-tva-/- cell              
clone infected by RCAS(B)GFP and RCAS(C)GFP, we observed none infected by both            
RCAS(A)GFP and RCAS(JS11C1)GFP. 
Taken together with previous findings of the similar host range, interference, sufficiency of             
Tva, and now necessity of Tva for RCAS(A)GFP and RCAS(JS11C1)GFP entry, we            
conclude that they share the same receptor while being separate subgroups, supporting the             
establishment of novel subgroup K represented by the JS11C1 isolate. 
Soluble form of tva receptor interferes with RCAS(JS11C1)GFP infection 
In order to investigate the direct interaction of the Tva receptor with the JS11C1 envelope,               
we used its soluble form (sTva) fused with a mouse immunoglobulin heavy chain (mIgG),              
termed sTva-mIgG, as described previously. 
Both RCAS(JS11C1)GFP and RCAS(A)GFP viruses were incubated with sTva-mIgG or          
mock control and then used for infection of naive DF-1 cells. Incubation of sTva-mIgG with               
RCAS(A)GFP resulted in total abrogation of infection, while incubation with          
RCAS(JS11C1)GFP resulted only in 77% inhibition of infection. To rule out the possible             
nonspecific interaction with mIgG, we repeated the experiment employing the soluble form of             
ALV-C subgroup receptor Tvc (sTvc) fused with mIgG (sTvc-mIgG). 
Incubation of sTvc-mIgG with RCAS(A)GFP or RCAS(JS11C1)GFP resulted in no inhibition           
of infection of naive DF-1 cells, showing that both RCAS(A)GFP and RCAS(JS11C1)GFP            




Figure A4.: ​Soluble Tva interference with      
ALV-A and ALV-K infection in susceptible      
cells 
RCASBP(A)GFP and RCASBP(JS11C1)GFP   
viruses were preincubated (filled columns) or      
mock-incubated (empty columns) with    
sTva-mIgG immunoadhesin and used for     
infection of DF-1 cells. Infection efficiencies      
are shown as means ± standard deviations of        
percentages of GFP-positive cells; the     
experiment was performed in triplicate. ​(Přikryl      






Figure A5.: ​Expression of the ​tva gene is sufficient and necessary for            
RCASBP(JS11C1)GFP infection 
(A) Efficiency of RCASBP(JS11C1)GFP and RCASBP(A)GFP infection in the Syrian          
hamster cell line NIL-2 ectopically expressing the ​tva gene (NIL-Tva). DF-1 cells were used              
as a susceptible control. Viruses with B and C specificity, i.e., RCASBP(B)GFP and             
RCASBP(C)GFP, respectively, and NIL-2 cells ectopically expressing the ​tvc gene were           
used as independent controls. Infection efficiencies are shown as percentages of           
GFP-positive cells and are presented as means ± standard deviations of triplicate assays.             
(B) The efficiency of RCASBP(JS11C1)GFP infection in intact DF-1 cells (left) and DF-1             
cells with a frameshift mutation in the ​tva gene (right), presented as FACS histograms of               
GFP-negative and GFP-positive cells. The relative GFP fluorescence is plotted against the            
cell count, and the percentage of GFP-positive cells is indicated. Typical results from             





RCAS(JS11C1)GFP induced pathology and lethality 
To investigate the pathology of the newly emerging subgroup, we inoculated 17 and 16              
brown leghorn embryos 12 days post fertilization with either RCAS(A)GFP or           
RCAS(JS11C1)GFP, respectively. Hatched chickens were maintained till sudden death, in          
case of severe pathology or termination of experiment, they were euthanized. Corpses were             
dissected with any abnormalities in morphology or neoplasia recorded. 
We observed rapid mortality of chickens infected with RCAS(JS11C1)GFP, culminating          
between days 10 and 23, with a total of 10 dead chickens coupled with the stunning disease                 
of the remaining chickens. Dissected animals displayed hemorrhage in the liver and            
muscles, hypertrophied heart and disruption of bone marrow integrity. The rest of the             
surviving chickens (7) were euthanized. Mortality induced by RCAS(A)GFP culminated          
between days 19 and 46, with a total of four dead chickens. One of the dissected animals                 
displayed disruption of the integrity of bone marrow and some suffered from ascites in the               
abdomen (data not shown). 
 
 
Figure A6.: Subgroup K induces rapid death in infected animals 
We inoculated 12-day-old embryos with RCAS(JS11C1) GFP or RCAS(A) GFP virus stocks            
and observed differing lethality. While more than half of RCAS(JS11C1) GFP-infected           
chickens rapidly died, RCAS(A) GFP-infected chickens showed lethality of about 40% and            








Mechanism of the host range extension 
RSV passage through mammalian cells induces env adaptation and host          
range extension 
To tackle the question of env-based host range extension, we analyzed the env sequence of               
PR-RSV-C passaged twice through mammals and compared it to the wt strain. The first              
passage was done by injection of tumor (generated by injection of PR-RSV-C into a chicken               
embryo) mince into rats, resulting in growth of a single tumor, labeled XC tumor and               
containing the XC-RSV strain. The second passage was done by injection of tumor             
(generated by injection of XC-RSV into a chicken embryo) mince into a Syrian hamster,              
resulting in growth of a single tumor, denoted H-20, containing the H20-RSV provirus.  
We identified eight amino acid substitutions in H20-RSV env sequence compared to wt             
PR-RSV-C, member of subgroup C. We also analyzed the XC-RSV env sequence and again              
observed all eight substitutions in all acquired env sequences in concert with H20-RSV,             
although the XC tumor contained multiple proviruses, in contrast to the H-20 tumor             
containing a single provirus. All found substitutions are dispersed over the whole env gene,              
some are located at the fusion peptide and heptad repeat regions, regions responsible for              
fusion of virus and host membrane with previously identified substitutions affecting the fusion             
machinery (see figure C1). 
As mammalian cells are normally nonpermissive for ALV because they lack specific            
receptors used by ALV subgroups, we infected Syrian hamster cell line NIL-2 and its derived               
cell line NIL-Tvc expressing the C subgroup-specific receptor, Tvc, by wt PR-RSV-C and             
H20-RSV and measured the amount of proviral DNA at different times. We observed similar              
amounts of proviral DNA in NIL-Tvc infected by both viruses. However, we observed nearly              
a two-log decrease of signal in NIL-2 cells infected by H20-RSV and more than a three-log                
decrease of signal in NIL-2 cells infected by PR-RSV-C. In all cases, we observed a               
decrease of signal over time in the infected cells. 
Since we detected a higher amount of H20-RSV DNA compared to PR-RSV-C DNA in the               
NIL-2 cell line, while the amounts of both viruses in the cells expressing the receptor is                
similar, we conclude that the H20-RSV strain exhibits an extended host range while retaining              






Figure C1.: ​Virus transmission to mammalian cells and envelope glycoprotein          
alteration 
(A) Scheme of rat and hamster infection with original PR-RSV-C virus. The PR-RSV-C virus              
was injected into a chicken, the resulting tumor was minced and injected into a rat, which                
developed a tumor caused by XC-RSV. The virus rescued from XC cells was again              
multiplied in a chicken and injected into a Syrian hamster, where the H20 tumor harboring               
H20-RSV was obtained (for details see Materials and Methods). (B) Diagram of the envelope              
glycoprotein domain structure with positions of described mutations responsible for          
mammalian tropism (black arrows) ​(Rainey et al. 2003; Amberg et al. 2006) and found amino               
acid mutations (red arrows). Host-range regions (hr1-2) and variable regions (vr1-3) in the             
surface subunit (SU) are depicted in gray boxes. The fusion peptide (FP), heptad repeats              
(HR1-2), and membrane-spanning domain (MSD) in the transmembrane subunit (TM) are           
shown in white boxes. (C) Comparison of gp85 amino acid sequences from original parental              
virus PR-RSV-C (sequence from GenBank ​V01197.1​) ​(Schwartz, Tizard, and Gilbert 1983)           
and viruses rescued from RSV-transformed rat (XC) or hamster (H20) cells. h and vr regions               
in SU are depicted in gray boxes. FP, HR1, HR2, and MSD in TM are shown in white boxes.                   
Their position is depicted according to refs. ​(Aydin, Smrke, and Lee 2013; Bova, Olsen, and               





Analysis of amino acid substitutions in H20 env 
For further analysis of H20-RSV env substitutions, we substituted RCAS(C)GFP env for            
H20-RSV env, creating RCAS(H20)GFP. To confirm the ability of H20-RSV env to enter             
mammalian cell lines is untouched in the new vector, we repeated the experiment described              
above using the new vector. While we observed a high amount of GFP-positive NIL-Tvc cells               
infected by both viruses, we detected GFP-positive NIL-2 cells infected only by            
RCAS(H20)GFP, though the signal was decreased by two logs, as observed in the previous              
experiment (figure C2). 
To investigate the role of individual substitutions, we divided the H20-RSV env into four              
regions using unique restriction sites and replaced the corresponding regions of           
RCAS(C)GFP. The following infection showed that only vectors bearing region 1 (containing            
D23G substitution) or 4 (containing L378S, G464S and L503V substitutions) can infect the             
NIL-2 cell line, as we observed GFP signal above the limit of detection. 
As region 4 contains three mutations, we used site-directed mutagenesis to introduce these             
mutations into RCAS(C)GFP. The following infection showed that only L378S substitution,           
located at the end of the fusion peptide, was sufficient to promote entry into Syrian hamster                
cells. 
To further investigate the effect of D23G and L378S substitutions on mammalian tropism, we              
infected human embryonic kidney cells (HEK293) and human telomerase reverse          
transcriptase (hTERT)-immortalized retinal pigment epithelial cells (RPE1-hTERT). Despite        
the fact that HEK293 cells were significantly more sensitive to infection with RCAS(C)GFP             
compared to NIL-2 and RPE1-hTERT, RCAS vectors containing the whole H20-RSV env,            
region 1, region 4, or L378S substitution showed the highest infection efficiency (figure C3). 
Furthermore, we confirmed the same results using a chicken cell line lacking Tvc receptor              
L15, with the highest infection efficiency mediated by the whole H20-RSV env, region 4,              
L378S, or region 1, respectively. 
In summary, both D23G and L378S enable virus entry into mammalian cells, both in concert               






Figure C2.: ​Viruses equipped with EnvH20 are able to infect hamster cells 
(A) The amount of newly produced ​env viral DNA in infected cells (NIL or NIL-Tvc) was                
quantified at different time points post-infection. The results were normalized to chGAPDH            
expression and are presented relative to the sample of NIL-Tvc-infected PR-RSV-C on day             
1. (B) Schematic diagram of chimeric reporter vector RCAS-EnvH20-GFP prepared from           
RCAS-EnvC-GFP and H20-RSV virus. Restriction sites and the position of primers used for             
the ​env gene substitution are depicted. (C) Infection of NIL and NIL-Tvc cells with              
RCAS-GFP viruses containing EnvC or EnvH20 was scored by flow cytometry 3 d later.              
Titers in GFP-transducing units were determined as described in Materials and Methods.            
Error bars show the SD of two independent experiments in parallel. The limit of detection               
(signal from uninfected NIL cells) is marked with a dashed line. Significant differences are              
marked by asterisks (***​P < 0.001). (D) Relative infectivity of NIL cells infected with              
RCAS-EnvC-GFP and RCAS-EnvH20-GFP. Infectivity is expressed as a percentage of the           
viral titer in NIL-Tvc cells. (E) Examples of FACS diagrams showing the percentages of              
GFP+ cells after infection of NIL cells with RCAS-EnvC-GFP and RCAS-EnvH20-GFP           





Premature activation of H20 env 
We observed significant loss of infectivity of RCAS(H20)GFP in our experiments with cells             
expressing the Tvc receptor compared to RCAS(C)GFP. This phenomenon can be           
explained either by lower production of virions or by decreased infectivity of the produced              
virions. To challenge this question, we measured reverse transcriptase activity and virus-like            
particle formation and found very small differences when comparing the viruses; therefore,            
we excluded the possibility of altered virion production and concentrated solely on the             
possibility of decreased virus infectivity (figure C4). 
Differences in infectivity in our RCAS-based system can be explained only by different             
stability or conformation of the respective env constructs. We tested the stability of             
RCAS(C)GFP and RCAS(H20)GFP envs by incubating viruses at 44°C at different times.            
Analysis of infected cells by both FACS and qPCR revealed a decreasing signal in cells               
infected by RCAS(H20)GFP. As env is relatively stable to heat and pH until it is primed by a                  
receptor, we also tested its sensitivity to low pH. While RCAS(C)GFP was nearly completely              
resistant to pH 5, RCAS(H20)GFP was inhibited more than four-log. 
As our observation suggested that RCAS(H20)GFP env is in its receptor-primed state            
regardless of the receptor, we exploited biochemical assays to test the conformations of the              
TM subunit of envs. First, we analyzed them by SDS/PAGE at both neutral and low pH. We                 
detected the signal for the non-primed state (approximately 30 kDa) in all samples, but the               
signal for the primed state (70-150 kDa) was observed only in samples containing TM              
subunits isolated from RCAS(H20)GFP, both at neutral or low pH. In our next experiment,              
we showed that RCAS(H20)GFP is able to bind liposomes regardless of the presence of a               
receptor, unlike RCAS(C)GFP. After mixing virions and liposomes and using density gradient            
centrifugation, we detected signals of virions at the bottom, while the signal of             
RCAS(H20)GFP was also detected at the top of the gradient since the liposomes could not               
be spun down and remained at top of the gradient. Virion-liposome complexes could be              
explained by exposure of the fusion peptide of the env TM subunit. To confirm that, we                
incubated virions with thiol-specific alkylating reagent PEG-maleimide-biotin (PMB), as the          
maleimide group reacts specifically with reduced thiols to form stable thioether bonds. It was              
shown that PMB selectively inhibits virions in a receptor-primed state. While RCAS(C)GFP            
was inhibited only by a high dosage (10mM) of PMB, RCAS(H20)GFP was fairly inhibited by               
a lower dosage (1mM) and nearly completely by a high dosage (10mM) of PMB. 
Taken together, our results suggest that env of H20-RSV has similar features to             






Figure C3.: ​Mutations in the first part of SU (D23G) and in the fusion peptide (L378S)                
are responsible for the virus-extended host range 
(A) Schematic diagram showing restriction sites (dashed lines) that were used to divide             
EnvH20 into four parts, which were tested separately as chimeras with EnvC. Positions of              
the found amino acid mutations are shown with red arrows. (B and D) Infection of hamster                
cell lines NIL and NIL-Tvc (​B​), human cell lines HEK293, RPE1-hTERT, and chicken L15 cell               
line (Tvc​−​) (D) with RCAS-GFP viruses harboring EnvC-H20 chimeras and          
RCAS-EnvC-GFP single mutants L378S, G464S, and G464S was scored by flow cytometry            
two (HEK293) or three (NIL, RPE1-hTERT, L15, NIL-Tvc) days later. Titers were determined             
as described in Materials and Methods. The limit of detection (signal from uninfected cells) is               
marked with a dashed line. (C) Relative infectivity of hamster NIL cells with different              
RCAS-GFP viruses is expressed as the percentage of the viral titer in NIL-Tvc cells. Error               
bars show the SD of two independent experiments in parallel. Significant differences are             
marked by asterisks (*​P = 0.05–0.01, **​P = 0.01–0.001, ***​P < 0.001). NS, not significant.               






Figure C4.: ​Virus harboring EnvH20 has a lower titer than the virus with original EnvC               
despite the same RT activity and VLP formation 
(A) Infection of NIL-Tvc and DF-1 cells with RCAS-EnvC-GFP and RCAS-EnvH20-GFP           
viruses was scored by flow cytometry two (DF-1 cell) or three (NIL-Tvc) days later. Titers               
were determined as described in Materials and Methods. The results are presented as titers              
relative to RCAS-EnvC-GFP. (B) RT activity of RCAS-EnvC and RCAS-EnvH20-GFP was           
measured using the PERT assay described in Materials and Methods. The results of the              
PERT assay are presented relative to RCAS-EnvC-GFP. (C) VLP production of DF-1 cells             
infected with RCAS-EnvC-GFP or RCAS-EnvH20-GFP was estimated by Western blot          
analysis. Expression of Gag product p27 in the medium was determined with anti-p27             





Receptor-independent entry correlates with instability of env 
To compare the ability to enter mammalian cells and sensitivity to low pH and PMB inhibitor,                
we expanded our analysis to RCAS(C)GFP bearing previously described regions of           
H20-RSV env. We observed that the virus bearing D23G substitution of region 1, coupled              
with mild ability to enter mammalian cells, was inhibited by low pH or PMB treatment only                
partially. The virus bearing L378S, G464S and L503V substitutions of region 4, coupled with              
high ability to enter mammalian cells, was highly inhibited by low pH or PMB treatment.               
Regions 2 and 3 showed inhibition similar to the wt PR-RSV-C env (figure C6). 
Taken together, we conclude that the level of inhibition correlates with the ability to enter Tvc                
null cells. 
Mutations of TM activate env regardless of the subgroup 
Since the most potent substitution for receptor-independent entry L378S was localized at the             
end of the fusion peptide of the TM subunit, we wondered whether the same substitution               
could promote receptor-independent entry of other subgroups. By cloning region 4 of            
H20-RSV env into the env of B subgroup, we created RCAS(B-H20part4)GFP and together             
with RCAS(B)GFP virus of subgroup B, we analyzed its ability to enter RPE1-hTERT cells              
and its inhibition by PMB. RCAS(B-H20part4)GFP showed similar levels of entry into            
mammalian cells and inhibition by PMB, which were not observed in RCAS(B)GFP (figure             
C7). 
These results suggest that the L378S substitution of TM can mediate premature activation of              
env regardless of the subgroup and support our hypothesis that viruses in our study can               
enter the cells in a receptor-independent way instead of binding to a non-specific ubiquitous              






Figure C5.: ​EnvH20 has similar features as a receptor-primed Env 
(A) The virus with EnvH20 is thermosensitive. Virus stocks of similar titers were incubated at               
44 °C for the indicated time. The titers were determined on NIL-Tvc 3 d after infection using                 
flow cytometry. The amount of proviral DNA in infected DF-1 cells was measured 1 d after                
infection using RT-PCR. The results are presented as the percentage of the original titer (full               
lines) or the amount of DNA (dashed lines) remaining after heating. (B) The virus with               
EnvH20 is inactivated by low pH. Purified viruses of similar titers were incubated with low               
(pH 5) or neutral (pH 7.5) treatment at 37 °C for 30 min before infection of DF-1 cells. The                   
titers were determined by flow cytometry 2 d later. (C) Formation of TM oligomers triggered               
by increasing temperature. The virus was incubated for 20 min at the indicated temperature.              
Samples were lysed in the Laemmli loading buffer and analyzed by SDS/PAGE without             
boiling. TM was detected by immunoblotting with an antibody against its C-terminal part.             
Only the 70-kDa isoform of TM is shown. (D) Formation of TM oligomers at low pH. The                 
virus was incubated for 30 min at the indicated pH at room temperature. Samples were               
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neutralized, lysed in Laemmli loading buffer, and analyzed by SDS/PAGE without boiling.            
TM was detected by immunoblotting with an antibody against its C-terminal part. (E) The              
virus with EnvH20 binds liposomes. Viruses of similar titers were incubated with or without              
liposomes at 37 °C and then the mixture was separated by sucrose gradient centrifugation.              
Sample fractions were collected and analyzed by Western immunoblotting using anti-p27           
antibody. T, top; B, bottom. (F) The virus containing EnvH20 is inhibited with PMB. Purified               
viruses of similar titers were incubated at 37 °C for 30 min with increasing concentrations of                
PMB. Viruses were diluted in medium and spinoculated on DF-1 cells. The percentage of              
GFP+ cells was measured by flow cytometry 2 d after infection. Titers below the limit of                
detection are marked with “<”. Error bars show the SD of two independent experiments in               
parallel. Significant differences are marked by asterisks (*​P = 0.05–0.01, **​P = 0.01–0.001,             
***​P​ < 0.001). NS, not significant. ​(Lounková et al. 2017) 
 
 
Figure C6.: ​The level of Env activation correlates with the efficiency of            
receptor-independent entry 
(A) Virus inactivation by low pH. Purified viruses harboring EnvC-H20 chimeras were            
incubated with low (pH 5) or neutral (pH 7.5) treatment at 37 °C for 30 min before infection of                   
DF-1 cells. The titers were determined by flow cytometry 2 d later. (C) PMB inhibition of virus                 
infection. Purified viruses harboring EnvC-H20 chimeras were incubated at 37 °C 30 min             
with increasing concentrations of PMB. The titers were determined on DF-1 cells by flow              
cytometry 2 d after infection. Titers below the limit of detection are marked with “<”. Error                
bars show the SD of two independent experiments in parallel. (B and D) Correlation between               
relative NIL infectivity and virus inactivation at low pH (​B​) or PMB inhibition of virus infection                






Figure C7.: ​Mutation in TM facilitates entry into mammalian cells independently of SU 
(A) Relative infectivity of human RPE1-hTERT cells with RCAS-EnvC-GFP,         
RCASBP-B-GFP, and RCAS-GFP viruses bearing chimeric Envs (SU-C or SU-B with TM            
from EnvH20) is expressed as the percentage of the viral titer on DF-1 cells. The percentage                
of GFP+ cells was scored by flow cytometry two (DF-1) or three (RPE1-hTERT) days after               
infection. (B) PMB inhibition of virus infection. Purified viruses were incubated at 37 °C for 30                
min with increasing concentration of PMB. The titers were determined on DF-1 cells by flow               
cytometry 2 d after infection. Titers below the limit of detection are marked with “<”. Error                
bars show the SD of two independent experiments in parallel. Significant differences are             








Figure C8.: ​Proposed model of receptor-independent entry 
(Left) Viral Env is normally activated by binding with the receptor. Activated Env takes a               
conformation enabling further changes that occur at low pH in endosomes and lead to viral               
and cell membrane fusion. (Middle) Mutations D32G and L378S change the EnvC            
conformation and shift Env close to the active state, which normally follows receptor priming.              
These viruses are therefore able to be spontaneously activated with efficiency, depending on             
the mutation type. After low pH exposure, activated Env facilitates viral and cell membrane              
fusion. (Right) The consequences of Env activation can be observed in different steps. The              
level of Env activation positively correlates with increased formation of reactive thiolate and             
decreased stability at low pH. After activation, the conformation is changed: heptad repeats             
are exposed and the fusion peptide is inserted into the liposome membrane. After low pH               
treatment, the formation of the six-helix bundle can be determined by TM oligomerization             







Envelope glycoprotein-driven osteopetrosis 
Two strains of MAV-2.O induce severe osteopetrosis, in contrast to its           
derivate, MAV-B 
Our studies took advantage of possession of three different stocks of MAV-2 viruses that              
differed extremely in their osteopetrotic potential. Two stocks (marked MAV-2.O and           
MAV-2.P) were derived from the original osteopetrotic MAV-2 stock and were (after a few              
passages in cell cultures and chickens) kept frozen for over 40 years. The third one (marked                
MAV-2.N) has originated from the same stock of MAV-2 but has undergone many passages              
in chickens when the virus obtained from nephroblastomas or adjacent cysts in one chicken              
generation was used to infect the next chicken generation; the virus has lost most of its                
osteopetrotic potential during the passages. MAV-2.N was molecularly cloned (the cloned           
virus was named MAV-B) and then engineered to carry fluorescent marker GFP (the product              
was named MCAS(B) - Přikryl 2015). Virus stocks were prepared by transfection DF-1 cells              
with relevant molecular clones and virus-containing medium was collected two weeks later. 
To compare quantitatively the oncogenic potential of our MAV strains, we have inoculated             
12-day chicken embryos with MAV-2.O, MAV-2.P, and MCAS(B) viruses. We observed only            
a low incidence of very mild osteopetrosis in chickens infected with MCAS(B) GFP even              
after more than two months, while both MAV-2.O and MAV-2.P induced rapid osteopetrosis             
in infected chickens starting 13 days after hatching and culminating 18 and 19 days after               
hatching, respectively. MAV-2.O, compared to MAV-2.P, induced remarkably more severe          
osteopetrosis and acted with higher penetrance (61% versus 42% of chickens, figure B1).             
Therefore, we have decided to continue our experiments only with two strains with the most               
divergent pathogenicity, MAV-2.O, and MCAS(B) GFP. 
We also tested the transforming ability of viruses in vitro by infecting CEF (chicken embryo               
fibroblasts) and overlaying them with agar. We observed no focus-forming colonies during            
more than three weeks, indicating neither MAV-2.O nor MCAS(B) GFP has the ability to              





Figure B1.: ​ ​Osteopetrosis-inducing strains of MAV-2 
(A) Relative number of brown leghorn chickens diagnosed with osteopetrosis upon           
inoculation at day 12 of embryonic development with MAV-2.O, MAV-2.P and MCAS(B)            
GFP. (B) The severity of osteopetrosis induced by MAV-2.O or MAV-2.P viruses. Severity is              
expressed in multiple categories based on the number of bones affected and the stage of               
bone transformation (enlargement). 
 
Osteopetrosis induced by MAV-2.O is not time- but dose-dependent 
Next we examined at which stage of chicken development the target cells of oncogenesis              
(presumably osteoblasts or their precursors) are available. We inoculated three groups of            
embryos at the different embryonic developmental stage: on day 10 (E10), 13 (E13), and 17               
(E17) and two groups of hatched chickens on the day of the hatch (K0) and 7 days later (K7)                   
with MAV-2.O and analyzed the incidence and severity of osteopetrosis. 
Group K7 developed no osteopetrosis but suffered from severe anemia, probably as a result              
of a fully functional immune system reaction to the virus. Other groups established             
osteopetrosis at a similar rate, with the first manifestation in group E10 (15 days              
post-inoculation), followed by K0 (18 dpi), E13 (20 dpi), and E17 (22 dpi). We also compared                
the severity of osteopetrosis of groups E17 and K0, to find out that the K0 group developed                 
mild-to-intermediate osteopetrosis while the E17 group developed severe osteopetrosis         
(figure B2). 
Furthermore, we inoculated chicken embryos on day 12 with MAV-2.O of different virus             
doses (10​^7​, 10​^5​, 10​^4​, 10​^3​, 10​^2​, 10​^1, and with the virus-free medium) and analyzed the               
hatched chickens. Although we detected osteopetrosis in all chickens infected with dose 10​^3             
and higher, a manifestation of osteopetrosis was delayed in chickens infected by dose 10​^5              
(day 37), 10​^4 (day 56), and 10​^3 (day 71), while only 75% of chickens inoculated by virus                 
dose 10​^2 and 20% of chickens inoculated by virus dose 10​^1 developed osteopetrosis by the               
end of the experiment (day 71). Also, the severity of the disease went down along with the                 
dosage of virus used for infection (figure B2). 
Taken together, our data suggest that there is no specific stage of embryonic development              
though infection must be carried out shortly after hatching at the latest to avoid the animal's                






Figure B2.:​ ​Osteopetrosis induced in a time- and dose-dependent way 
(A) Relative number of chickens diagnosed with osteopetrosis regardless of the severity            
induced by MAV-2.O inoculation at different stages of embryonic development, starting at            
day 10 (E10), followed by days 13 and 17 (E13, E17), the day of hatch (K0) and even days                   
post-hatching (K7). (B) Chickens infected before hatching displayed a higher number of            
affected bones and the affection was greater. (C) Relative number of chickens diagnosed             
with osteopetrosis regardless of the severity induced by inoculation of MAV-2.O of different             
titers (10 ​̂7 and 10 ​̂5 to 10 ​̂0​) with a low incidence of disease by titer 10 ​̂2 and lower. (D) The                   
severity of osteopetrosis is dose-dependent, as chickens with non-diluted virus struggled           
with a high amount of transformed bones, while viruses of titer 10 ​̂2 and below were able to                 






Comparative analysis of MAV-2.O and MAV-B 
To look for genetic variations responsible for the strong osteopetrosis potential of some MAV              
strains, we sequenced proviruses in DNA from osteopetrotic tissue and normal liver from             
several chickens infected with MAV-2.O and compared them with MAV-B (molecularly           
cloned MAV-2.N). We identified a number of nucleotide substitutions in the whole genome of              
MAV-2.O. To select substitutions crucial for osteopetrosis induction, we applied the following            
criteria: 1) the substitution generates missense mutation and/or is inside known regulation            
regions, i.e., LTR NRS (a negative regulator of splicing), gag enhancer, env SA (env splicing               
enhancer), 2) the substitution is present in the majority of MAV-2.O samples (as with all               
retroviruses, uncloned MAV-2 is composed of many quasispecies), 3) (where applicable) the            
substitution is present in the majority of other sequenced ALV strains with high osteopetrotic              
potential while it is not present in the majority of ALV strains with low osteopetrotic potential.                
Selected substitutions are presented in Table B1. We found multiple substitutions within U3             
(nucleotides 160 and 194), U5 (nucleotide 372), integrase (A683V and M765V - numbers             
according to the whole pol protein), TM (L387S and A398T - numbers according to              
processed env protein), and one substitution affecting both integrase and signal sequence of             






Table B1.: Comparative analysis of multiple ALV strains and selection of osteopetrotic            
potential of MAV-2.O-derived substitutions 
We sequenced the genome of MAV-2.O and compared it to osteopetrotic MAV-2(O) and             
recombinant MAV1/2(O) strains ​(Joliot et al. 1993) and nonsteopetrotic strains MAV-2(N)           
and MAV-1(N) ​(Watts and Smith 1980) and other ALV strains (see Materials and Methods).              
The level of the potential association of substitutions with osteopetrosis is expressed from “-”              
(no correlation) to “+++” (strong correlation). Gray highlighted substitutions appear to have            
no effect on osteopetrosis induction or do not alter the amino acid sequence, while              
substitutions highlighted with green and red have a possible effect on the disease induction              
and progression. For our initial experiments, we introduced substitutions highlighted with           





Osteopetrosis induced by vectors bearing MAV-2.O-derived substitutions 
To test the significance of the selected substitutions, we have introduced them, one by one               
as well as in combinations, into the MCAS(B) clone using fusion PCR mutagenesis; for the               
list and specification, see figure B3. We started the evaluation with constructs containing all              
substitution (LPE), all substitutions in LTR+pol (LP), in pol+env (PE), and in LTR+env             
excluding the one in int/env signal peptide overlap (LE) or including it (LE+). We inoculated               
12-day chicken embryos with mutagenized viruses (collected from transfected DF-1 cells)           
together with MAV-2.O (positive control) and observed osteopetrosis development for 49           
days after which the chickens were euthanized. As we have seen before, MAV-2.O induced              
rapid onset of severe osteopetrosis. LP virus was able to induce only mild osteopetrosis              
starting to appear in 50 % of chicken between days 35 and 42. All constructs bearing env                 
substitutions induced rapid and severe osteopetrosis in all animals starting with LPE            
(presumably between day 7 and day 14), followed by LE+ (day 14), PE and LE (both                
between days 14 and 21), indicating a principal role of the env gene in osteopetrosis               
induction (figure B3). Comparison of these numbers also demonstrates that substitutions in            
LTR and pol, though they have only a moderate effect, both presumably synergize with env               
substitutions.  
As most of the animals infected with mutagenized MCAB(B) died or were euthanized within              
two months after hatching, we observed no other tumors than osteopetrosis with the             
exception of chickens infected by MCAS(B)-LP GFP developing a similar panel of tumors as              







Figure B3.: Osteopetrosis induced by MAV-2.O-derived genes 
(A) Table of all selected substitutions and acronyms used for vectors. (B) All vectors bearing               
MAV-2.O-derived envelope glycoprotein proved their ability to affect the infected chickens in            
a similar fashion as the MAV-2.O virus regardless of additive regions of MAV-2.O. The              
vector bearing MAV-2.O-derived LTR and pol (LP) was able to transform only about half of               




locus LTR pol pol/env env 
substitution 160 194 372 A683V M765V S880N/A28T L387S A398T 
LP x x x x x x - - 
LE x x x - - - x x 
LE+ x x x - - x x x 
PE - - - x x x x x 
LPE x x x x x x x x 
 
MAV-2.O env-derived substitutions render the virus unstable, more        
sensitive to temperature, less infectious and capable of infecting         
receptor-less cells 
Further experiments were done using cell cultures instead of animals and were aimed to              
elucidate how the substitutions changed the basic properties of the virus, like the stability              
and efficiency of infection and propagation. Constructs carrying individual substitutions in           
env and all their possible combinations were included in the experiment so that we were able                
to assess the importance of individual substitutions. Vectors containing A28T substitution are            
coded P3 (for pol/env shared locus), L378S containing vectors are coded T1 (for TM locus)               







Figure B4. Scheme of substitutions and produced vectors. 
(A) Schematic representation of envelope glycoprotein. Variable regions (vr1-3, hr1-2) within           
the surface subunit are depicted in white boxes, the fusion peptide (FP), heptad repeats              
(HR1-2), and membrane-spanning domain (MSD) of transmembrane subunit are depicted in           
grey boxes. Positions of selected MAV-2.O env-derived substitutions are marked with black            
arrows. Substitution responsible for mammalian tropism is marked with a red arrow. 
(B) Table of MAV-2.O env-derived substitutions and names of constructed vectors. 
 
Only a low proportion of DF-1 cell become GFP-positive after infection by T1 (16%), P3T1               
(25%), and P3T12 (6%) viruses compared to other viruses (average 72%), suggesting            
corruption of envelope glycoprotein containing L387S substitution alone or in combinations           
with others (Figure B4). 
Env destabilization may be a manifestation of e.g. decreased activation energy for env             
priming, which would lead to spontaneous self-priming and, in addition to decreasing env             
longevity, it would make the virus able to enter cells lacking the respective receptor. To               
attest this possibility we generated, using CRISPR/Cas9 system, DF-1 knockout cell line            
without functional Tvb gene and attempted to infect this cell line, denoted DF-1ΔTvb, with              
our mutagenized viruses. In the first experiment we observed no infection, exactly as with wt               
MCAS(B). Since we realized that some of our viruses poorly infected even cells with the               
functional receptor, we adjusted our infection protocol by increasing both the amount of the              
virus preparations and the duration of the treatment. Using this protocol (from now on called               
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 P3 T1 T2 P3T1 P3T2 T12 P3T12 WT 
A28T x - - x x - x - 
L378S - x - x - x x - 
A398T - - x - x x x - 
 
adjusted infectivity test), we could detect a low GFP signal in DF-1ΔTvb cultures infected              
with any of our viruses (0,48% of cells in culture on average, figure B4) with exception of wt                  
MCAS(B) GFP which failed to infect DF-1ΔTvb cells even under adjusted infectivity            
c​onditions, while the virus was able to infect DF-1 cells (for more details, see figure B5).  
Since the data supported our conjecture, we tested the constructs for another symptom of              
facilitated priming: increased temperature sensitivity. We exposed the viruses to 44°C for 12             
or 24 hours prior to infection of DF-1 cells and compared remaining virus infectivity with               
untreated viruses (figure B6). MCAS(B) GFP sustained the highest infectivity (50% after 24             
hours of incubation at 44°C), while most vectors bearing substitutions sustained only partial             
infectivity, starting with the most stable T12 (34%), followed by P3 (17,5%), P3T12 (14%), T1               
and T2 (both 10%), P3T1 (9%) and ending with the least stable P3T2 (6,5%). 
Taken together, we have shown that changed properties of the viruses with substitutions in              
env (decreased stability and infectivity as well as acquired ability to infect receptor-less cells)              





Figure B5.: ​ ​Infectivity of DF1 and DF-1​ΔTvb​ by different vectors 
We have cloned all selected substitutions into the MCAS(B) GFP vector, alone or in              
combination, and used them for infection of cells expressing or lacking the Tvb receptor. (A)               
Vectors infected DF-1 cells with differing efficiency. We observed the lowest GFP-positive            
cells infected by the vector with all substitutions or only T1 substitution. We repeated              
infection using 10-times more virus to observe an enhancement of infection in most cases,              
while the vector with T1 substitution displayed only minor enhancement. (B) We infected             
DF-1​ΔTvb in the same fashion and observed infection only by vector bearing MAV-2.O-derived             




Figure B6.: MAV-2.O-derived substitutions provide raised thermosensitivity 
We incubated vectors at 44°C for 0, 12 or 24 hours and used them for infection of DF-1 cells.                   
The numbers of GFP-positive cells infected by vectors incubated for 12 or 24 hours were               





MAV-2.O env-derived substitutions affect A and C subgroups envelope         
glycoproteins similarly to B subgroup env 
To further scrutinize MAV-2.O-specific env substitutions and to see whether their effect is             
restricted to subgroup B, we introduced the substitutions into a new context of subgroup A, C                
and K envelope glycoproteins using MCAS(A), MCAS(C) and MCAS(K) vectors with           
structure analogical to that of MCAS(B). Subgroup specificity resides in variable parts of SU              
subunit while TM subunits are highly homologous, thus the TM-localized L387S and A398T             
amino acid residues (the sites of T1 and T2 substitutions) together with their vicinity are               
conserved in A, C, and K subgroups. The A28 residue in the env signal peptide (the site of                  
P3 substitution) was not examined since A28T is already present in subgroups A, C and K. 
First we tested infectivity on DF-1 cells. According to the numbers of GFP-positive cells, A               
subgroup virus with T1 (A-T1) and C subgroup virus with T1 and T2 (C-T1, C-T2)               
substitutions showed approximately 10-times lower infectivity compared to the respective wt           
virus. As for the double substitution in env C, infectivity was reduced 100-times. Neither T2               
(A-T2) substitution in A subgroup nor any substitution in K subgroup affected the infectivity of               
the virus (figure B7). 
Next, we performed the same test using receptor-less DF-1 cells, using DF-1​ΔTva and             
DF-1​ΔTvc cells, cell lines with an off-frame deletion in Tva or Tvc genes induced by               
CRISPR/Cas9, respectively, by subgroups A and K viruses (DF-1​ΔTva) and by subgroup C             
viruses ​(DF-1​ΔTvc). C subgroup T1 virus was able to enter about 1% of receptor-less cells,               
while neither C subgroup T2 (C-T2) or T12 (C-T12) were able to infect these. None of the                 
substitutions provided subgroup A and K viruses with the ability to infect receptor-less cells. 
To test thermal stability, mutagenized A, C and K subgroup viruses were incubated at 44°C               
for 12 and 24 hours prior to DF-1 cell infection. Significant decrease of infectivity was               
observed in all cases. The A subgroup viruses retained only ca 75% after 12 hours of                
incubation and less than 25% after 24 hours, for the K subgroup the numbers were               
25%/~0% and for the C subgroup 10% /~0%. 
Temperature 44°C in our experimental setup was chosen based on the literature and our              
previous experiments. For very unstable viruses (like our mutagenized subgroups K and C),             
however, it might be too high. To better compare the stability of the respective viruses, we                
soften the test conditions for C and K subgroup viruses to 24 hour incubation at 33°C, 37°C,                 
or 40°C (figure B8). At these temperatures we could observe differences between individual             
substitutions. For the C subgroup, we found the greatest decrease of infectivity with T12              
virus (retention of 50%, 15%, and 5% after incubation at 33°C, 37°C, and 40°C,              
respectively), while single substitutions separately showed infectivity reduction 50%, 40%,          
and 10%, respectively. Surprisingly, we observed no infectivity reduction with any of our K              
subgroup viruses under the above conditions which contrasted sharply with our results when             
using incubation temperature 44°C (see above). 
Taken together, our data suggest that MAV-2.O env-derived substitutions, when introduced           
into subgroup A and C envelope glycoproteins, have some effects similar to those we              
described for subgroup B: they make the protein less stable which reduces virus infectivity.              
The third symptom, ability to infect receptor-less cells, was observed only with mutagenized             
constructs of the C subgroup. Subgroup K demonstrated none of the above-mentioned            






Figure B7.: ​Infectivity of different subgroup based vectors 
We introduced MAV-2.O-derived substitutions into A, C and K subgroup envelope           
glycoproteins and used them for infection of DF-1 cells (A) and cells lacking             
subgroup-specific receptors (B). Only the C subgroup T1 substitution proved a significant            
difference to the wt C subgroup (​P < 0.01). Next, we incubated C subgroup (C) or K                 
subgroup (D) vectors for 0, 12, and 24 hours at 44°C and used them for infection of DF-1                  







Figure B8.: C and K subgroup vectors show different thermosensitivity 
We incubated C subgroup-derived vectors at 33°C (A), 37°C ©, or 40°C (E) for 12 or 24                 
hours and used them for infection of DF-1 cells. The same scheme was used for K                





Additional substitution L154S in envelope glycoprotein enhances       
infection of receptor-less cells 
We can presume that the osteopetrosis connected env destabilizing substitutions scrutinized           
above are not the only ones that can incite the phenomena. In our previous work (Přikryl                
2015) we have analyzed the L154S substitution in B subgroup envelope glycoprotein,            
selected on the basis of its ability to mediate infection of receptor-less cells (​(Rainey et al.                
2003)​)​. We have shown that this substitution also incites env destabilization and promotes             
(though very mild) osteopetrosis. To expand our results and compare effects of L154S             
substitution with those described above, we introduced it into our MCAS(B)-based constructs            
denoted “E”, for ​“extended host range”. 
Test of infectivity of these new constructs on DF-1 cells showed a high number of               
GFP-positive cells after infection with E (60%) or ​P3E (87%) vectors. Other viruses (ET1,              
ET2,...) managed to infect DF-1 cells only with an average of 9% GFP-positive cells. Vector               
ET12 was not used for infection as we failed to propagate the virus in tissue culture. Since                 
the failure might be caused by excessive damage to envelope glycoprotein due to the              
introduced substitutions, we constructed the ET12neo vector with the neomycin resistance           
gene connected to the GFP gene via P2A self-cleaving peptide. After three-week-long            
selection by G418, we harvested the virus and used it together with other vectors, using our                
adjusted infecting protocol to infect DF-1 cells. We observed a high amount of GFP-positive              
cells infected by E (94%) and P3E (67%) constructs, mediate amount of GFP-positive cells              
infected by ET1 (42%) or P3ET1 (32%) and low amount of GFP-positive cells by P3ET2               
(13%), ET2 (10%), ET12 (10%) or P3ET12 (4%) constructs (figure B9). 
Next we examined virus infectivity on DF-1​ΔTvb cells using both standard and ​adjusted             
infectivity tests. We observed the most efficient infection with ​E (54%), followed by ET1              
(42%) and P3ET1 (39%) when infected by our adjusted protocol. Other vectors infected the              
DF-1​ΔTvb cells in 10% of GFP-positive cells on average (figure B9). 
 
 
Figure B9.: ​Infectivity of MAV-2.O-derived substitutions coupled with L154S         
substitution-bearing vectors 
We introduced the L154S substitution into our vectors and used them for infection of DF-1               
cells (A) or ​DF-1​ΔTvb cells (B). We used both a low (0.1 ml) and high (1 ml) amount of virus                    






The aim of this thesis was to analyze envelope glycoproteins with possible receptor             
recognition shifts. We have tested JS11C1, the prototype isolate of the postulated new K              
subgroup, RSV-H20, provirus successfully integrated into a mammalian cell line, and           
MAV-2.O, highly osteopetrotic strain. All investigated viruses present unique insights into the            
virus-host evolution arm race, as they managed to overcome the obstacle of occupied             
receptors or absent specific receptor in non-permissive species. 
 
JS11C1 ​switched receptor specificity due to extensive changes in domains responsible for            
receptor recognition. We have synthesized its envelope glycoprotein, cloned it into a RCAS             
vector, creating RCAS(JS11C1) GFP and: 
● found unique host range, differing from other ALV subgroups 
● observed interference between RCAS(JS11C1)GFP and RCAS(A)GFP 
● identified a sufficient and necessary receptor used by JS11C1, Tva, shared with            
subgroup A viruses 
● observed differing inhibition efficiency between JS11C1 and RCAS(A)GFP by soluble          
Tva receptor 
● observed rapid mortality in chickens infected by RCAS(JS11C1)GFP 
Our observations verify the existence of new ALV subgroup K and its importance for further               
research of avian retroviruses evolution and pathogenicity.  
 
RSV-H20 invaded mammalian cells through either interaction with the unknown cell receptor            
or env destabilization. To distinguish between these two possibilities we have: 
● sequenced and cloned env of RSV-H20 into a RCAS vector, resulting in the             
RCAS(H20)GFP vector and identified amino acid residues coupled with the          
cross-species transmission 
● verified the capacity of selected substitutions to activate the envelope glycoprotein           
independently on the receptor and thus providing association with artificially made           
liposomes 
● discovered RCAS(H20)GFP high temperature and low pH sensitivity, along with the           
sensitivity to a selective inhibitor typical for activated prefusion state env 
Taken together, these findings support the assumption of receptor-independent cell entry of            
RSV H20.  
 
MAV-2.O induces chicken osteopetrosis by an unknown mechanism involving the envelope           
glycoprotein and LTR. We studied the characteristics of osteopetric variants of env and             
conclude that: 
● identified substitutions of amino acid residues within env are associated with           
MAV-2.O induced chicken osteopetrosis 
● mutations in nucleotide sequence of LTR and substitutions of amino acid residues            
within pol are not directly responsible for the disease induction but potentiate the             
disease progress when coupled with MAV-2.O env-derived substitutions 
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● env-derived substitutions destabilize the envelope glycoprotein and predispose the         
virus to infect receptor-less cells 
● MAV-2.O env-derived substitutions are not subgroup-specific, providing similar        
capacity to A and C subgroups 
● envelope glycoprotein-provided receptor-less entry and observed destabilization is        
further enhanced by SU-derived L154S substitution 
We suggest that the envelope gene destabilization is involved in osteopetrosis induction.            








In our studies, we focused on retroviral variants and their changed interaction with             
permissive and nonpermissive cells. Three unrelated chicken viruses were investigated:          
JS11C1 virus postulated to be the prototype virus of the newly emerged ALV-K subgroup,              
RSV-H20, a variant of RSV-C, C-subgroup virus found integrated into hamster-derived cell            
line and MAV-2.O, a B-subgroup virus capable of inducing osteopetrosis. In the case of              
JS11C1, we sought to identify the receptor for subgroup K viruses. Regarding RSV-H20 we              
questioned the possibility of the virus infection via a novel molecule present both at avian               
and mammal hosts as RSV-C enters the avian cells using the Tvc receptor. Concerning              
MAV-2.O, we looked for virus genetic determinants for osteopetrosis induction, which,           
incidentally, converged to the same issue: the possibility of involvement of its envelope             
glycoprotein in tumorigenesis via an unknown mechanism. We employed classical virological           
methods such as superinfection interference assay and infectivity assay using different cell            
lines and primary cell cultures together with biochemical methods such as lipid-binding            
assay and pH based neutralization assay. 
The K-subgroup virus study 
In the first study, we aimed to verify that the viruses assigned to the K subgroup really                 
represent a new subgroup since this definition was based solely on ​env gene sequences.              
The first step was to verify if these viruses actually do not fit into some of the older                  
subgroups. For this reason, we infected a panel of cell lines and primary cultures derived               
from a set of outbred or inbred chicken strains as well as multiple non-chicken Galliformes               
fibroblasts with a retroviral vector carrying JS11C1 env, with the intent to compare the              
sensitivity of these cells to subgroup K versus subgroup A. The experiment showed a good               
(but not absolute) correlation of host range between A and K subgroups, suggesting both              
subgroups use the same receptor. The evidence was supported by parallel experiments with             
Tva-null chicken cells and mammalian cells expressing Tva (Tva is ALV-A specific receptor)             
showed that JS11C1 is able to enter cells via this molecule. Either RCAS(A) or MCAS(A)               
GFP vectors were used as ALV-A viruses; both gave the same results. 
To further confirm that A and K subgroups share the same receptor, we carried out a               
superinfection interference assay. The principle of the assay consists in the ability of env              
glycoprotein, produced by infected cells, to occupy the receptor and/or to block its             
env-binding site so that no further virus of the same subgroup can enter the cell. We found                 
that pre-infection with ALV-A or with JS11C1 viruses rendered the cells resistant to             
superinfection with both ALV-A and JS11C1 viruses, while susceptibility to other subgroups            
was maintained, in full agreement with the above-stated assumption.  
To tell the whole story, we have to mention some observations that did not conform to the                 
theory. We observed that the ratio between infection efficiency of ALV-A versus JS11C1 was              
different in different cells and there were even cells that were resistant to ALV-A but not to                 
JS11C1 and vice versa. The ALV-A-resistant/JS11C1-susceptibility cells carried already         
described alleles with known resistance-rendering substitutions. This discrepancy can be          
explained in two ways. Either, A and K env glycoproteins bind different epitopes on the              
receptor so that the affinities to the two glycoproteins evolved independently. 
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Further experiments tested the infectivity of the two viruses in the presence of a selective               
inhibitor of ALV-A entry - soluble form of Tva (sTva). Contrary to ALV-A, infection with the                
JS11C1 virus was not fully inhibited by sTva. A plausible explanation of this discrepancy is               
that the bulky IgG domain hampers sTva interaction with env-K more than with env-A. That               
would imply, in turn, that the two glycoproteins bind either to different epitopes or indifferent               
ways. The results provide no clue as to which of the above scenarios is true. 
In summary, we postulate JS11C1 and related viruses as an independent K subgroup since              
they display host range different from other subgroups. Although they share the receptor             
(Tva) with A subgroup, they recognize different epitopes or recognize the same but contact it               
in a different way. Using the same receptor, however, manifests itself by reciprocal             
interference between A and K viruses and by similar (but not identical) host range. 
Finally, we investigated the pathological effects of infection with K subgroup viruses in vivo.              
Brown Leghorn chickens, after being inoculated with JS11C1 as embryos, exhibited           
significantly higher mortality compared to chickens infected with ALV-A. After dissection, we            
observed severe pathology in JS11C1-infected chickens, represented by muscle         
hemorrhages, enlarged heart, ascites in the abdomen and disrupted the integrity of bone             
marrow (data not shown). These symptoms were similar to the symptoms caused by the              
FGV (fowl glioma virus) group of viruses, so far classified to A subgroup ​(Tomioka et al.                
2003; Nakamura et al. 2011)​. Surprisingly, when we compared env glycoprotein sequences            
from K subgroup viruses with those of many other viruses, we found members of the FGV                
group to be significantly closer to K than to A (data not shown), indicating that FGV viruses                 
might belong to the K subgroup. 
Furthermore, new isolates are continuously emerging ​(X. Zhou et al. 2019; Su, Li, Li, et al.                
2018; Zhao et al. 2018b) with the potential to cause harm to the farming industry similar to                 
subgroup J ​(Lv et al. 2019)​. The problem of receptor specificity appears to be even more                
complex since some strains of K subgroup exhibited unusual behavior in receptor            
recognition and interfering with A subgroups viruses ​(Mingzhang et al. 2018) and distinction             
interaction of some ALV-A strains with Tva were shown ​(Melder et al. 2015)​. Also, isolate               
GDFX0601 of K subgroup appears to have mixed receptor specificity (Jianyong, unpublished            
data), questioning its interaction with Tva receptor, therefore, appears crucial and priority in             
the future. The same analysis should be performed for FGV viruses-derived env. Since both              
K subgroup and FGV group viruses are strongly pathogenic, obtained information could be             
of great practical use, e.g. for the development of resistant chicken strains via modification of               
the Tva gene. 
RSV-H20 virus study 
In the second study, we have investigated the RSV-H20, the C subgroup RSV variant              
present, as a provirus, in hamster cell line transformed with Pr-RSV-C. First, we examined              
whether this ability is limited to hamster or, more widely, to rodent cells. We generated an                
RCAS vector carrying RSV-H20-derived env (RCAS(H20) GFP) and used it to infect several             
mammalian cell lines, including human ones. In all cases, we observed a greatly increased              
proportion of infected cells with RCAS-H20 compared to wt RCAS-C, even in cells like              
HEK293 which showed a high background of infection with wt RCAS-C. However,            
mammalian cells engineered to express the chicken Tvc receptor showed much higher            




Next, we looked for genetic determinants in H20 env that are responsible for its unique               
properties. We have sequenced the H20 env gene and identified multiple substitutions            
compared to wt RSV-C. With this knowledge, we divided the H20 env into four parts each                
carrying a proportion of the identified substitutions and by swapping them in RCAS-C we              
generated four chimeras each carrying only a single part of the H20 env. Then we examined                
the infectivity of the chimeras on mammalian cell lines. We found that the infectivity              
correlated with the presence of the first or fourth part while swapping the second or third part                 
had no effect. The first part contained only one substitution, D32G. In the fourth part, there                
were three substitutions, L378S, G464S, and L503V. Therefore, we separated these           
substitutions and investigated them separately. Only L378S substitution rendered the env           
glycoprotein capable of infecting mammalian cells; the effect was stronger than in the case              
of D32G substitution. 
Then we asked how the virus managed to enter mammalian cells known to lack the               
functional receptor for the C subgroup. We considered the possibility that substitutions in env              
provided it with the ability to interact with mammalian versions of chicken Tvc, or it could use                 
quite different molecules on the mammalian cells. However, since RCAS-H20          
indiscriminately infected all tested cells and infection was enhanced by mammalian cells            
expressing Tvc receptor, we favored the hypothesis that it enters mammalian cells via a              
receptor-independent pathway. Under normal circumstances, envelope glycoprotein is in a          
metastable state with fusion peptides hidden inside the envelope´s trimeric structure. The            
glycoprotein has the competence to undergo conformational rearrangements leading to the           
fusion peptides exposure (so-called prefusion state). This process, however, requires          
lowering its activation energy, rendered by an interaction with a receptor; this process is thus               
called receptor-mediated priming. The decrease of activation energy can also be achieved            
by some mutations in env, leading to its destabilization (which is meant as the propensity to                
undergo transitions to prefusion and then postfusion states, not propensity to denature) so             
that it gradually and spontaneously undergoes rearrangement; this we will call self-priming.            
Spontaneous rearrangements make the virus able to fuse with cells regardless of a receptor.              
On the other hand, it decreases env stability since prematurely activated env undergoes             
further spontaneous rearrangements (most probably corresponding to the transition from the           
prefusion state into the postfusion state) thus causing depletion of infectious particles. 
To confirm our assumption we tested characteristics of env. One of them is the decreased               
stability at elevated temperature (44°C) or in an acidic environment (pH 5) ​(Bova-Hill, Olsen,              
and Swanstrom 1991; W. Mothes et al. 2000)​. Indeed, H20 env, as well as chimeric envs,                
shown to infect mammalian cells, manifested a faster decrease of infectivity at 44°C as well               
as in low pH in comparison to wt env-C. Another parameter is the ability to associate with                 
liposomes which was probed using the so-called lipid-binding essay. The virus was            
incubated with liposomes and the association was monitored by ultracentrifugation in           
sucrose gradient where the virus-liposome complex sediments to intermediate density,          
separately from free liposomes and free virus. The assay showed that RCAS-H20 as well as               
chimeric mammalian cells-infecting viruses associated with liposomes, contrary to wt          
RCAS-C. Finally, we used PMB, which reacts selectively with cysteine thiol groups on fusion              
peptides that become accessible only after priming, thus acting as the inhibitor of env-driven              
membrane fusion. PBM effectively inhibited infection of mammalian cells with RCAS-H20           




When we compared all measured properties of our viruses we found that they perfectly              
correlated - the viruses ranked in the same order when we compared infectivity on              
mammalian cells, instability at increased temperature or low pH, and sensitivity to PBM: wt              
RCAS-C < RCAS-C(D32G) < RCAS-C(L378S) < RCAS-H20. 
Therefore we believe that the phenomenon of avian retroviruses entry into mammalian cell             
lines is based on a receptor-independent process that proceeds via self-priming of variant             
env glycoproteins.  
MAV-2.O virus study 
In the last, yet unfinished study, we examined the MAV-2.O virus which is unique by its                
ability to induce osteopetrosis in infected chickens. Avian osteopetrosis is a disorder            
characterized by enlarged and thickened bones, caused by virus-induced hyperproliferation          
of osteoblasts. We took advantage of possessing both MAV-2.O and its direct descendant,             
MAV-2.N, which has lost most of the osteopetrotic potential during passaging ​in vivo and ​in               
vitro​. MAV-2.N induced late-onset osteopetrosis with barely detectable symptoms in ca 15%            
of chickens compared to 100% of severe rapid-onset osteopetrosis induced in chickens by             
parental MAV-2.O. In the starting experiments, we also examined a close relative of             
MAV-2.O, named MAV-2.P, which has shown to have slightly reduced osteopetrotic potential            
compared to MAV-2.O. We then concentrated solely on comparing MAV-2.O versus           
MAV-2.N (the latter after molecular cloning, generating MAV-B virus and then after inserting             
GFP gene, generating MCAS(B) virus (Přikryl et al., 2015)). 
After a comparative analysis of the two viruses ​in vivo and adjusting the experimental              
conditions for osteopetrosis induction, we turned our attention to comparative genetic           
analysis. The two viruses were sequenced and sequences aligned. We revealed multiple            
point substitutions from which we, in the first step, selected those lying in important              
regulatory regions (e.g. LTR) as well as missense mutations residing inside the genes             
(encoding integrase, signal peptide, and a transmembrane subunit of envelope          
glycoprotein). In the next step, we pinpointed potentially important substitutions in this            
collection by comparing them with corresponding sequences of other ALVs for which both             
the sequence and ability or inability to induce osteopetrosis was known, including several             
close relatives of MAV-2. We ended up with three substitutions in LTR, two substitutions in               
integrase, two substitutions in TM domain of env, and one substitution affecting both             
integrase and signal peptide of env. 
Pinpointed substitutions were introduced into MCAS(B) virus, first individually (using fusion           
PCR mutagenesis), and then in different combinations (with the help of swapping or additive              
fusion PCR mutagenesis). MCAS(B) variants generated this way were then scrutinized for            
the ability to induce osteopetrosis in infected chickens; wt MCAS(B) and MAV-2.O served as              
a negative and positive control, resp. We started with variants carrying all MAV-2.O-specific             
substitutions in LTR, in integrase, or in env and continued with variants carrying all possible               
combinations of these three groups of substitutions. Substitutions in env turned up to be by               
far the most effective since the results of infection with MCAS(B) variants carrying a              
combination of substitutions in TM with substitutions in integrase or in LTR were quite              
consistent: adding more substitutions always increased the osteopetrotic potential though          
the auxiliary effect of substitutions in LTR and/or in integrase was only mild. However,              
though MCAS(B) variant carrying all selected substitutions proved to be very potent, it did              
not fully reproduce the osteopetrotic potential of MAV-2.O, indicating that further mutations in             
MAV-2.O, which did not get through our selection process, might have a supportive effect.              
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The missed mutations might also be present only in a subpopulation of viruses in MAV-2.O               
stock, which was not produced from the molecular clone and thus is a mixture of               
quasispecies. Such mutation would not be recorded by Sanger sequencing.  
In our previous work (Přikryl et al., 2015) we examined the MAV-2-derived virus-carrying             
L154S mutation in the SU domain of env. The mutation was originally identified by Rainey               
and his colleagues ​(Rainey et al. 2003; Rainey and Coffin 2006) because of its ability to                
enter mammalian cells; the phenomenon was named "extended host range". We found that             
this virus also promotes osteopetrosis (with high penetrance but very mild symptoms) and             
carries destabilized env glycoprotein. We realized that all these properties might be            
connected (and might ensue from the phenomenon of self-priming). Therefore, we switched            
from experiments on living animals to in vitro essays and explored the possible effect of               
MAV-2.O-specific substitutions on env stability and virus potential to infect receptor-less           
cells. For this purpose, we constructed a chicken cell line (DF-1ΔTvb) lacking Tvb, a              
subgroup B-specific receptor. Then we generated MCAS(B) variants carrying individual          
MAV-2.O TM-specific substitutions, individually and in combinations, and tested their effect           
on virus entry into DF-1 versus DF-1ΔTvb cells. Compared to what we have seen previously               
for L154S substitution, all MAV-2.O-specific substitutions showed decreased infectivity on          
DF-1 cells and only very low infectivity on DF-1ΔTvb cells. To see it at all we had to use an                    
adjusted infection protocol with increased both virus dose and treatment period; yet, it was              
still meaningful since wt MCAS(B) had nearly zero infectivity on DF-1ΔTvb cells under the              
same conditions.  
We assume that the low infectivity of our MCAS(B) variants results from decreased stability              
of the respective env glycoproteins. To verify it, we performed a temperature stability assay              
(incubation of the viruses at 44°C for 12 or 24 hours) and looked for a decrease in infectivity.                  
As expected, all substitution made the env more temperature-sensitive. This result supports            
our assumption that the ability to induce osteopetrosis correlates with the destabilization of             
the env glycoprotein as well as with the ability to infect receptor-less cells and that all these                 
properties are just signs of the same phenomenon - env self-priming.  
To examine whether L154S substitution synergizes with the substitutions found in MAV-2.O            
TM, we constructed viruses carrying individual MAV-2.O-specific substitutions together with          
L154S substitution and tested their infectivity on wt and receptor-less cells. The L154S             
substitution alone provided strong receptor-independent infectivity compared to wt env while           
preserving infectivity on DF-1 cells, which suggests that the mutated env remained relatively             
stable. When added to other substitutions it also strongly enhanced receptor-independent           
infection; however, some of the triple or quadruple substitution variants displayed low            
infectivity on both types of cells alike the relevant substitution alone, meaning that the              
env-destabilizing effect of relevant substitutions was retained in the presence of L154S            
substitution. Infectivity of one triple substitution variant was so attenuated that we were             
forced to produce the virus with the help of a selection marker to be able to propagate and                  
harvest the virus, yet we could clearly detect its infection of the receptor-less cells. These               
results show, again, that all three observed phenomena (extended host range or the ability              
to infect receptor-less cells, env destabilization, and ability to induce osteopetrosis) are            
connected and may have a common ground - self-priming.  
Destabilization of A, C, and K subgroups 
Many previous works, including our own, showed that the receptor-less entry is not limited to               
a specific subgroup. Therefore, we used receptor-less cells DF-1ΔTva and DF-1ΔTvc and            
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constructed A, C, and K subgroup viruses bearing MAV-2.O TM-specific substitutions L378S            
and A398T (we could not make A28T substitution since, in A, C and K subgroups, T is                
already present at the position 28). Then we tested the infectivity of these viruses on wt                
versus receptor-less cells (see figure B7). 
The strongest effect was observed in the A and C subgroup vectors with L378S substitution               
present in the envelope glycoprotein. This substitution disrupted the viruses ability to            
efficiently infect DF-1 cells while providing successful infection of Tvc-null cells by the C              
subgroup virus. Though this finding was in conjunction with our previous project since L378S              
substitution is present in the H20-derived provirus, we observed no impact on the K              
subgroup viruses. Through incubation of our vectors in different temperatures, we also            
confirmed the destabilization of our C subgroup vectors. The fact we failed to detect any               
anomalies in the K subgroup substituted vectors implies this subgroup is special in terms of               
both stability and SU-TM cross-talk, offering a unique opportunity to further understanding of             
envelope glycoprotein mechanisms. 
Possible role of self-priming in coevolution of env and receptor 
Co-evolution of ALVs and their receptors still remains to be better documented. Nowadays             
envelope glycoproteins and glycoproteins of endogenous proviruses, together with their          
corresponding receptors, are the only remaining traces of the past evolution. A group of              
closely related glycoproteins that evolved from a common precursor can be most            
informative. By comparing such a set of glycoproteins with a corresponding set of receptors              
and by delineating their productive interactions, and by taking into account the presence, in              
relevant hosts, of endogenous proviruses carrying related envs, we can track down how             
arms race between the virus and its host proceeded.  
Our results provided useful material for the study of env-receptor interactions. An example is              
our finding that the newly emerging subgroup K utilizes the same receptor as A subgroup but                
A and K env glycoproteins interact with Tva in a different way. A similar situation is                
represented by subgroups B, D, and E that recognize the same receptor, Tvb ​(Heather B.               
Adkins, Brojatsch, and Young 2000)​. In all these cases, a plausible scenario of how              
subgroups recognizing the same receptor originated is the following: to prevent interaction            
with the specific virus subgroup, the env-binding epitope on the host´s receptor has             
changed. The virus reacted by adapting its receptor-binding domain so that the interaction             
with the receptor was restored, binding the different epitope. This might also result in              
changes in host range, as different alleles are found across species, and thus fulfilling the               
criteria for establishing a new subgroup by an adapted virus. Such a scenario might apply               
not only on the changes in recognition of different epitopes of the same receptor, but also on                 
the changes in different receptors recognition, as was simulated by Mark Federspiel ​(Mark J.              
Federspiel 2019) 
Similarly, the phenomena of self-priming or extended host range, which we studied using             
RSV-H20 and MAV-2.O viruses, could play an essential role in the virus-host arms race.              
Uncoupling virus entry from receptor recognition would facilitate virus evolution as it provides             
the chance for the virus to adapt to changes in cells that attempt to prevent virus entry. The                  
uncoupling, however, has a negative impact on virus viability as it is connected with env               
destabilization. Therefore, as soon as the virus is sufficiently adapted, natural selection            
favors more stable variants that, concurrently, lose the ability to enter the cells lacking a               
functional receptor.  
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In our experiments, we have found substitutions with different effects on envelope            
glycoprotein stability as well as on virus infectivity on receptor-less cells. The following table              
compares viruses carrying these substitutions with regard to the infectivity on DF-1 and             
DF-1ΔTvb cells as well as titer remaining after incubation at 44°C for 12 hours. By               
normalizing the infectivity on DF-1ΔTvb cells to infectivity on wt DF-1 cells we can set the                
effect of self-priming apart from the decrease of stability; the number obtained tells us what               
infectivity on DF-1ΔTvb cells we would see if the virus remained stable. The results clearly               
show the following: First, the reduced infectivity on DF-1 cells (row 1) correlates well with               
decreased stability as measured at 44°C (row 4). Second, the ability of self-priming (row 3)               
correlates well with env destabilization (row 4). 
 
 
We presume that there exists a perfect grade of env glycoprotein stability (in chemical terms,               
the optimal level of activation energy for priming). There are two reasons for this supposition.               
First, the trigger for receptor priming must be sensitive enough so that env, after interaction               
with the receptor, undergoes proper rearrangement with sufficient speed and efficiency.           
Second, there is a clear evolutionary advantage in having env glycoprotein just on the verge               
of instability; then, when functional receptors become unavailable, a single or a few             
substitutions can generate env capable of receptor-independent entry into the cells.  
In this context, we have to take into account yet another factor. Retroviruses have a high                
rate of mutation and recombination, therefore every retroviral population is a mixture of many              
pseudo species. Under conditions of a high multiplicity of infection (a condition which is              
fulfilled in the infected chickens and especially in osteopetrotic bone) two pseudo species,             
one carrying a destabilizing mutation in env can meet the same cell. Such cells then produce                
env trimers which contain both stable and destabilized env. It is plausible to assume that the                
destabilizing effect is attenuated in heterotrimer which enables the destabilized env to            
escape selection pressure and maintain its presence (at a certain level) in the virus              
population. Moreover, the high recombination rate of retroviruses leads to a perpetual            
exchange of individual mutations between viruses; if destabilization requires more than one            
mutation, a pool of such mutations may remain in the virus population. 
Connection between osteopetrosis and env destabilization 
To explain how self-priming relates to osteopetrosis induction we have to combine two facts.              
Firstly, the virus capable of entering receptor-less cells is naturally also able to enter the               
cells that already have been infected with the same virus, in other words, to escape               
superinfection resistance. As a result, an unlimited number of viral particles can enter each              
cell. Secondly, hyperproliferative osteoblasts from osteopetrotic tissue are characterized by          
an extremely high load of unintegrated viral DNA (up to hundreds of copies). Of course,               
there are more questions than answers but no question remains a complete mystery. To              
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vector P3 T1 T2 P3T1 P3T2 T12 P3T12 L154S WT 
DF-1 93% 21% 85% 50% 92% 82% 19% 94% 70% 
DF-1ΔTvb 0.44% 0.55% 0.58% 0.35% 0.36% 0.37% 0.69% 54% 0.04% 
DF-1ΔTvb normalized 0.47% 2.62% 0.68% 0.70% 0.39% 0.45% 3.63% 57% 0.06% 
12h at 44°C 85% 37% 71% 60% 64% 84% 33% n.d. 100% 
 
some questions we can bring forward plausible explanations, about some we can at least              
speculate and all of them can be solved experimentally. 
We failed to conclude whether the excessive accumulation of viral DNA in osteopetrosis is a               
cause or consequence. We also failed to analyze the nature of LTR- and pol-derived              
substitutions on viral expression and integration. Furthermore, since the extended host           
range provided by SU- and TM-derived substitutions could be explained by env            
destabilization, we are failing to understand the nature of signal peptide-derived substitutions            
effects. The mutated env-B-Tvb interaction might also provide some information, as the Tvb             
receptor is reported to be a functional death receptor antagonized by the NF-κB pathway              
(Jürgen Brojatsch et al. 2000; Chi et al. 2002)​. Finally, it is also to be determined why viruses                  
selected for the ability to enter receptor-less cells have relatively stable env (e.g. the env               
with L154S substitution), while viruses selected for their osteopetrotic potential mostly           
possess quite unstable env (e.g. the MAV-2.O env). The answer may lie in different              
conditions under which the two viruses replicate. Virus released by cultured cells diffuses             
into the media, spends most of its life far away from any cell, and needs plenty of time to                   
succeed in contacting another cell; the long lifespan of env glycoprotein thus confers a great               
selective advantage. In contrast, the virus released by osteoblast is imprisoned in a small              
lacuna around the osteoblast and comes repeatedly into contact with the same cell from              
which it was released; thus, even short-lived env can fulfill its task. Indeed, electron              
microscopy pictures of osteopetrotic bone show lacunas densely packed with virions ​(Foster            
et al. 1994)​. Furthermore, MAV-2.O-derived may prove to be more fusogenic compared to             
L154S. Hyperfusogenocity was proved to be the cause of some measles-related fatal            
syndromes in humans ​(Jurgens et al. 2015)​. Since other substitutions in the TM subunit              
coupled with the extended host range ​(Amberg et al. 2006) and osteopetrosis ​(Barbosa et al.               
2010) were reported, we expect to encounter even more promising substitutions worth            
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